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ABSTRACT 
 
 
Title: Effectiveness of cold pack Application on acute episodic pain among patients 
with Migraine in OPD at Government Rajaji Hospital, Madurai. Objectives: To 
assess the level of Acute Episodic pain among patients with Migraine .To evaluate the 
effectiveness of cold pack intervention on Acute Episodic Pain among patients with 
Migraine intervention group.  To associate the level of acute episodic pain among 
patients with migraine with their selected socio demographic variables and clinical 
variables in OPD at Government Rajaji Hospital, Madurai. Hypotheses: There is a 
significant  difference  between  the  level of acute episodic  pain    among   patients 
with  migraine   in OPD  at Government Rajaji Hospital,    at  Madurai .There is a 
significant association between the level of acute episodic pain among patients with 
migraine with their selected demographic variables.  Conceptual Framework: 
Modified Imogene kings goal attainment theory Methodology: Quantitative approach 
– True experimental - pre test post test only design. Sample size was 60, selected by 
Simple random sampling technique. International Headache society Criteria was used 
to assess symptoms of pre test ,pain assessment by using numerical rating scale . Cold 
pack application applied two times    with an half an hour interval daily in the 
morning .post test was done by using the same tool. Findings: The findings revealed 
that there was a significant reduction in the level of acute episodic pain after cold 
pack intervention, which was confirmed by paired ‘t’ test. The ‘t’ value is 22.47 p 
value at 0.001 level of significance. Pain score report showed significant reduction 
Conclusion: This study statistically proved that Cold pack application was very 
effective in reducing Pain among patients with migraine. 
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CHAPTER I 
INTRODUCTION 
 “No one knows our body or our subjective experiences like we do” 
 Sarah Hackley. 
  Health is a state of wellbeing of an individual, and is not only physical health 
but also including a mental health. There is nothing in our life that is more valuable 
than a good health, without health there is no happiness, no peace, and no success. In 
day to day life we are facing so many problems that lead to stressful situations. These 
stress induces physical problems, mental discomfort. In hospital settings out patient 
department different type of clients will take treatment for their complaints like pain, 
headache, with nausea, and vomiting, body ache, stomach pain and diarrhoea etc. For 
any type of discomfort the individual seek and undergo prescribed treatment as per 
doctors order in Hospital settings at outpatient department. 
  Headache is one of the most common physical complaints of all human being. 
Headache is the commonest symptom for which people seek medical advice from 
doctors. The most common type of headache is migraine. Migraine is typically 
described as a sick headache, since the patient apart from headache feels very sick. The 
name “migraine” goes thousands of years back to the time of Hippocrates, who called 
the aliment ”hemicranias”, a Greek term meaning “half skull”, since the headache 
affects usually one half of the head. 
  Migraine is a primary headache disorder characterized by recurrent 
headache that are moderate to severe. Typically the headache affect one half of the 
head, and pulsating in nature, and last from 2 to 72 hours with the associate symptoms 
may include nausea, vomiting, and sensitivity to light, sound, or smell. The pain is 
generally made worse by physical activity. Up to 1/3 of people have an aura: typically 
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a short period 5-60 minutes of visual disturbance which signals that the headache will 
occur soon. Occasionally, an aura can occur with little or no headache following it on.  
.  Migraine can manifest in different ways and the most characteristic feature of 
migraine headache is Unilateral pain. Ancient Greek and Egyptian writings show that 
physicians of that time were concerned about this disease and they treat it with 
bloodletting and craniotomy in some patients with headache. There are about 100 
million peoplewith headache in U.S about 37 million of these people have migraines 
the world health organization suggest that 18% of women and 7% present of men in the 
U.S suffer from migraines in the year 2015. 
  Migraine is a genetic neurological disease, characterized by episodes often 
called Migraine attacks. They are quite different from regular headache .Migraines are 
believed to be due to a mixture of environmental and genetic factors. About 2/3 of cases 
run in families, Changing hormone levels may also play a role, as migraines affect 
slightly more boys than girls before puberty and 2 to 3 times more women than men. 
Twins indicate a 34% to 51% genetic influence of likelihood to develop migraine 
headache. This genetic relationship is stronger for migraines with aura than for 
migraines without aura. A number of specific variants of genes increase the risk by a 
mild to moderate. Single gene disorders that result in migraines are rare. One of these 
is known as familial hemiplegic migraine, a type of migraine with aura, which is 
inherited in an autosomal dominant fashion. Four genes have been shown to be involved 
in familial hemiplegic migraine. Three of these genes are involved in ion transport. The 
fourth is an axonal protein associated with the exocytosis complex.  
  Migraine sufferers may have moderate or severe pain and usually can’t 
participate in normal activities because of the pain. Some persons have pain on just the 
right side or left side of the head, others result in pain all over. Often when a migraine 
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strikes, people try to find a quiet, dark room. Different people have different triggers and 
different symptoms. Some people experience aura, which can cause changes in vision. 
Sufferers have reported can’t seeing flashes or bright spots. Although an exact cause is 
unknown, brain scan shows that migraines may be due to “hyperactivity” in parts of the 
brain. Actually, a migraineur brain is biochemically different than that the brain of a 
person without this disorder. 
  Migraine headache is generally treated by anti-migraine agents, analgesics and 
anti-emetic agents. Various non-pharmacological methods including massage, trigger 
point therapy, reflexology, spinal manipulation therapy, therapeutic heat or cold 
application, acupuncture, bio feed back, yoga and exercise therapy have also been 
investigated in the past for migraine patients. Pain is the most common symptom for 
physician consultation in most developed countries. It is a major symptom in many 
medical conditions, and can interfere with a person's quality of life and general 
functioning. Simple pain medications are useful in 20% to 70% of cases. Psychological 
factors such as social support, hypnotic suggestion, excitement, or distraction can 
significantly affect pain's intensity or unpleasantness. Migraine sufferer alarmingly 
describe the migraine bouts like hit over the head with a hammer, inside of the head 
repeatedly jabbed with a sharp object or having their head stabled with Needles. 
  Migraine triggering factors such as Stress, lack of sleep, food additives, hunger 
or dehydration ,highly caffeinated drinks, medication over use, alcohol, odour or strong 
smells, bright light, loud sound, over use of pain medication such as nonsteroidal anti 
inflammatory drugs, changes in weather, hormones, excessive physical activity certain 
foods trigger migraine, foods such as citrus fruits, cheese chocolates, fasting may 
trigger the migraine.  
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  In a basilar migraine, a migraine with neurological symptoms related to 
the brain stem or with neurological symptoms on both sides of the body, common 
effects include a sense of the world spinning, light-headedness, and 
confusion. Nausea occurs in almost 90% of people, and vomiting occurs in about one-
third. Other symptoms may include blurred vision, nasal stuffiness, diarrhoea, frequent 
urination, pallor, or sweating, neck stiffness, Swelling or tenderness of the scalp may 
occur.  
Migraine medications are considered effective if they reduce the frequency, 
severity of the migraine attack. Medications such as topiramate, divalproex, sodium 
valproate, propranolol, metoprolol, gabapentin, pregbalin, timolol, amitriptyllin and 
venlafaxine are effective in migraine frequency. while frovatriptan is effective for 
prevention of menstrual migraine. Botulinum toxin (Botox) to be useful in those with 
chronic migraine. 
 
1.1 Need for the study 
  Migraine is a throbbing headache characterized by moderate to severe pain. 
Migraine is an important public health problem, particularly among women during their 
reproductive age group. Migraine control is important, through careful history and 
diagnosis of the patient. This should broadly be the control of symptoms to minimize 
the impact of the illness on the patient's life and lifestyle. If there is a management plan 
includes abortive, and alternative management considered. General measures include 
advice on sleep, relaxation and stress management; yoga, meditation, cold therapy, and 
physical fitness may help to reduce the susceptibility to migraine. 
  The prevalence of migraine headaches is high, affecting roughly 1 out of every 
7 Americans annually, and has remained relatively stable over the last year. Prevalence 
of migraine 18% of women, and 7% of men get migraines sometime in their lifetime. 
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About half of these people get their first migraine before the age of 20, and 98% before 
the age of 50. 5% get migraine before they're 15 years old, and about a third of those 
get migraine before they're even 5 Most migraines, however, occur between the ages of 
25 and 50.  Before puberty, girls and boys are almost equal in the migraine they suffer, 
possibly due to the estrogen changes that women go through at various stages in life. 
About 70% have close (first degree) relative with migraine .Many people suffer from 
migraine it is strongly linked with stress. In Government Rajaji Hospital, Madurai, Out 
Patient Department of Neuro Medicine, 8 to 10 patients of Migraine attending clinic 
everyday for the treatment. 
  Globally, it has been estimated that prevalence among adults of current 
headache disorder is about 50%. Half to three quarters of adults aged 18–65 years in 
the world have headache in the last year and, among those individuals, 30% or more 
have reported migraine. Headache on 15 or more days every month affects 1.7–4% of 
the world’s adult population. Despite regional variations, headache disorders are a 
worldwide problem, affecting people of all ages, races, income levels and geographical 
areas. 
  There are about 100 million people with headache in United states about 37 
million of these people have migraine the world health organization suggest that 18% 
of women and 7% present of men in the United states suffer from migraines in the year 
2015. 
  Prevalence of head ache in India was 63.9%,with female preponderance 0f 4:3, 
migraine was25.2%, higher among females than males 2:1,among those rural area to 
urban1.5,tention type head ache 35.1%, all head ache≥15 days/ month3.0% ,medication 
over use Head ache was 1.2%. 
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  There are four types of therapeutic management for migraine patients as follows 
General measures, abortive therapy, pain relief measures and prophylactic therapy. 
Various non-pharmacological methods including massage, reflexology, spinal 
manipulation therapy, therapeutic heat or cold application, acupuncture, Biofeed back, 
Transcutaneous electric nerve stimulation and exercise therapy have also been 
investigated in the past for migraine patients. There are some reports which support the 
efficacy of cold application in the treatment of migraine Head ache. 
A study conducted on 9 million American men who suffer from migraines 
probably avoid headache trigger like alcohol, a different kind of cocktail symptoms. 
Recent researcher presented at the American Academy of neurology reveals that a new 
treatment can nearly eliminate the migraine frequency. In the study of 2,900 migraine 
sufferers, those who took 85milligram (mg) of the prescription drug Imitrex and 
500mg of Naproxen at the onset of an attack experienced a 72% reduction in pain over 
4 hours, relief from nausea and reduced sensitivity of light and sound. “Naproxen cuts 
down on inflammation while Imitrex stop brain cell activity that can exacerbate 
migraine pain” says Stephen Silberstein MD. 
  A study, the efficacy of extra-cranial pressure in combination with cold to treat 
headache was supported. They showed that simultaneous pressure of heat and cold 
reduced the headache duration. Today, some patients report that they treat their 
headache using physical therapies, including cold application. In 90% of all affected 
people, migraines appear at an early age, particularly in the age of 30. Women are 
affected almost twice as much as men. In people over the age of 60, migraine seems 
to be an exception. Family forms have been reported, but there is no evidence that the 
condition is passed on from one generation to another. Of course, not every headache 
is a migraine headache, and it was not until 1988, that the specialists of the 
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International headache society were able to agree on a general classification of the 
affliction.  
  Researcher, during the clinical posting observed that the acute episodic pain 
patients with migraine had unbearable type of head ache. In Government Rajaji 
Hospital Madurai every day patients will come for the complaints of migraine and got 
treatment. Researcher reviewing the literature, need to intervention of cold pack 
application to reduce the pain intensity. Prophylactic therapies which gives maximum 
benefit at minimum cost. Researcher found that cold pack application review is few, so 
review collected from articles, and journals Researcher intended to evaluate the 
effectiveness of cold pack intervention on acute episodic pain among patients with 
Migraine. All these made the researcher to do the study.  
 
1.2 Statement of the Problem 
A study to evaluate the effectiveness of Cold pack application on Acute episodic 
pain among patients with migraine in OPD at Governtment Rajaji Hospital Madurai 20. 
 
1.3 Objectives 
1. To assess the level of acute episodic pain among patients with migraine both 
intervention group, and control group in OPD at Government Rajaji Hospital, 
Madurai.  
2. To evaluate the effectiveness of cold pack application on acute episodic pain 
among Intervention Group patients with migraine in OPD at Government Rajaji 
Hospital Madurai. 
3. To associate the level of acute episodic pain among patients with migraine in 
OPD at Government Rajaji Hospital, Madurai with their selected socio 
demographic variables.  
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1.4 Hypotheses 
 H1 There is a significant difference between pretest and post test level of acute 
episodic pain among Intervention group patients with migraine, in OPD at 
Government Rajaji Hospital, at Madurai.  
 H 2 There is a significant difference between the post test level of acute episodic 
pain among intervention group, and control group patients with migraine in 
OPD at Government Rajaji Hospital, at Madurai.  
 H3 There is a significant association between the level of acute episodic pain 
among patients with migraine with their selected demographic variables. 
 
1.5 Operational definitions 
Effectiveness: 
In this study it refers to the intended outcome of applying cold pack on acute 
episodic pain among patients with migraine and it is measured by pain numerical rating 
scale in terms of significant Values in the post test.  
 
Cold Pack Application 
In this study Cold pack application refers to administration of cold pack bag 
contains water with ammonium Nitrate, calcium ammonium nitrate, or urea. In these 
chemicals dissolved in water produce endothermic reaction. Application of gel pack 
covered by small towel with 80c over fore head for 20mts two times a day with half an 
hour interval to reduce the acute episodic pain.  
 
Acute Episodic Pain  
  In this study acute episodic pain refers to an unpleasant sensation experienced 
by who are diagnosed as migraine, and it is measured by pain numerical rating scale. 
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Patients with Migraine 
  In this study refers to patients who are diagnosed as migraine and attending the 
outpatient department Government of Rajaji Hospital, Madurai.  
 
Out Patient Department  
  In this study outpatient department refers to Neuro Medicine outpatient 
department in which migraineur, exclusively treated for their level of acute pain.  
  
1.6 Assumptions 
Patients with migraine may have experience varying level of pain. 
 
1.7 Delimitation  
The study was limited to patients with migraine attending outpatient department 
at Government Rajaji Hospital Madurai.  
The sample size is limited to 60 subjects 
The study period is limited to 4to 6 weeks.  
 
1.8 Projected Outcome 
 Cold pack application will reduce the level of acute episodic pain among 
patients with migraine in OPD at Government Rajaji Hospital Madurai. 
  
 
 
 
 
 
 
 
 
REVIEW OF 
LITERATURE 
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CHAPTER-II 
REVIEW OF LITERATURE 
 
Review of literature is a key step in the research process. It refers to an 
extensive, exhaustive and systematic examination of publications relevant to the 
research project. The important purpose of literature review is to convey to the readers 
about the work already done, knowledge and ideas that have been already established 
on a particular topic of research. 
 
This chapter is divided into two parts: 
Part I- Review of literature 
Part II - Conceptual framework 
The review of literature has been done for the present study “To evaluate the 
effectiveness of, of cold pack application on migraine from published articles, journals, 
textbooks, reports, projects, dissertations, Medline, and internet search. Finally the 
review of literature was organized and presented as follows: 
 
1. Review Literature Related to Migraine Head Ache 
2. Review Literature Related to Cold Pack Application. 
3. Review Literature Related to Effectiveness of Cold Pack Application on 
Migraine  
4. Review Literature Related to Other Treatment on Migraine 
 
2.1. Review Literature Related to Migraine Head Ache  
T N Vijayalakshmi1, Ratna Manjushree et al (2016) Conducted a Clinical 
study to evaluate the visual evoked potential for migraine patients in Madras Medical 
College to know the pathogenesis of migraine in between attacks among 30 migraine 
11 
 
patients compared with 30 normal persons. The results were statistically significant 
increase in amplitude of P100 wave of migraine patients due to deficient habituation 
after a period of 15 min stimulation, after that, decrease in amplitude of normal 
patients.The results revealed that increase amplitude of p100wave, in migraineur has 
interictal dysfunction than in normal patients. 
T Kurth tobias. (2015) Conducted prospective cohort study in united states, to 
evaluate the association between migraine and incident cardiovascular disease and 
cardiovascular mortality in women. Participants involved in the study115541 women 
aged between 25-42 years at baseline and free of angina and cardiovascular disease, 
among17 531 (15.2%) women reported as migraine, Over 20 years of follow-up, 1329 
major cardiovascular disease occurred and 223 women were died from cardiovascular 
disease. Migraine was associated with an increased risk for major cardiovascular 
disease (hazard ratio 1.50, 95% confidence interval 1.33 to 1.69), myocardial infarction 
(1.39, 1.18 to 1.64), stroke (1.62, 1.37 to 1.92), and angina, coronary revascularization 
procedures (1.73, 1.29 to 2.32), compared with women without migraine. The results 
revealed that, migraine was significantly associated with increased risk for 
cardiovascular disease, mortality (hazard ratio 1.37, 1.02 to 1.83). 
Smitherman TA, Burch R, et al (2014) conducted a population based study to 
estimate the prevalence of migraine head ache, measures of disability, treatment 
pattern. the National Health Interview Survey, the National Health and Nutrition 
Examination survey, American migraine prevalence and prevention study done in U.S. 
slightly higher proportion of 22.7% in the National Health and Nutrition Examination 
Survey, 16.6% of adults 18 or older reported having migraine or other severe headache. 
According to AMPP study overall prevalence of migraine of 11.7% and probable 
migraine of 4.5%, for a total of 16.2%, the burden of headache was highest in females 
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18-44 severe head ache 26.1%, males 4.6%,triptons used 80%. The prevalence and 
burden of headache was substantial even in the least affected subgroup previous 3 
months. Results revealed that migraine associated increased risk of physical and 
psychiatric co morbidity.  
Teri Robert (2013) Conducted a study large-scale population-based study to 
assess frequent Migraine attacks and and have a long history of Migraines an Increased 
risk of "silent brain damage," brain damage that does not seems to cause any symptoms. 
Study involved 28 patients with Migraine using high-resolution T1- and diffusion-
weighted MRI and other advanced technology to identify areas of any damage to the 
brain. The researchers also used the technology to examine the brains of 28 patients 
without Migraine, as a control group. Migraineur who experience Migraine with aura 
have an increased risk of white matter lesions, and the risk of such lesions was increased 
even more with increased Migraine attack frequency. Results revealed that migraine 
may be a progressive brain disease. 
 Kulkarni G,  RaoG et al (2010) Conducted a study to estimate the prevalence 
and disability burden attributed to migraine in Karnataka. Population based study used 
to select subjects random cluster sampling in urban n=1,226 and rural n=1,103 
populations using a Modified Hardship questionnaire. Migraine was diagnosed as per 
ICHD-II criteria, Disability was assessed by HALT index. Age-standardized 1-year 
prevalence was 25.2% (95% CI: 23.9-27.4%; 10.6% definite, 14.6% probable 
migraine). Point prevalence 2.7%. Prevalence was greater among females and in rural 
areas. Prevalence peaked between 35-45 years in both genders and median frequency 
was 24 days/year, with a minority (6.6%) reporting >60 days/year, Headache intensity 
was severe in 40%. The overall mean total was 3.7 ±6.1 days/3 months, representing a 
loss of 6.1% of productive days, of which 2.1 ±4.0 days/3 months were lost at home 
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and 1.4 ±4.1 days/months were lost in the work place. Results revealed that Disability 
was higher among women and in rural areas.  
Dr. Suzanne Hagler (2009) Conducted a study at Cincinnati Children's 
Hospital medical center evaluated over 7,400 participants, researchers took baseline 
levels of riboflavin, vitamin D, folate and coenzyme Q10. A high percentage of the 
children, teenagers and young adults had mild CoQ10, vitamin D and riboflavin 
deficiencies may cause Migraine. In young women and girls were more likely to 
experience a CoQ10 deficiency and boys were more to suffer from vitamin D 
deficiency. Participants suffering from chronic migraines at regular intervals had an 
increased risk of CoQ10 and riboflavin deficiency, compared to those with episodic 
migraines occurring at infrequent intervals. alarming 16% to 51 %of participants had 
below average levels of vitamins depending on the vitamin tested. These deficiencies 
are determined by the National Academy of Sciences Dietary Reference Intakes 
(DRIs). These national levels are set to prevent disease. A lack of magnesium may 
promote a number of different illnesses, including depression, platelet aggression, 
serotonin receptor function and influence production and use of neurotransmitters. 
Researchers revealed that migraine may develop due to the magnesium deficiency, 
CoQ10, vitamin D, riboflavin deficiency. 
Markus Schruks, MD, et al, (2008) Conducted a meta analysis study to 
evaluate the association between migraine and mortality in America. Systematic review 
of  Meta analysis study done, heterogeneity among study is moderate to high and pooled 
analyses of migraine subtypes cause-specific mortality. For any migraine pooled 
analysis does not suggest an association with all-cause (five studies; pooled relative risk 
[RR]=0.90, 95%CI 0.71–1.16), cardiovascular (CVD; six studies; pooled RR=1.09, 
95%CI 0.89–1.32), or coronary heart disease mortality (CHD; three studies; pooled 
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RR=0.95, 95%CI 0.57–1.60). The studies revealed that migraine with aura increases 
risk for Cardio Vascular Disease and Coronary heart disease mortality. 
Polyana Cristina Vilela Braga(2007) Conducted a cross sectional study to 
identify the occurrence of head ache as major cause of pain ,and characterizing effect 
on every day activities of nursing under graduate students at college of nursing of the 
federal university of goias,Brazil. Participants involved 203 students mean age 21 years 
48.5% economic class A. Headaches were the major cause of pain for 34.5% of 
students; have strong intensity; throbbing (74.3%), stabbing (62.9%), and nausea / 
vomiting (55.7%); with episodes occur in afternoon (52.9%), and lasting for several 
hours a day (51.4%). On set of pain were: studying (17.1%) and stress (11.4 %). The 
activities most affected were: their capacity to concentrate (84.3%) and mood (84.3%) 
(p<0.05).Results revealed that headache, affect the students' everyday activities. 
Cao Z, Chuang CT, CH Lai KL (2005 ) conducted a clinical trial study to 
compare resting-state EEG energy intensity and effective connectivity in different 
migraine phases involved patients with migraine without aura as compared with 
healthy controls in united states. 50 patients with episodic migraine, 20 Healthy control 
completed the study. Patients were classified into inter-ictal, pre-ictal, ictal, and post-
ictal phases (n = 22, 12, 8, 8, respectively), using 36-h criteria. Compare healthy 
control,to inter-ictal and ictal patients had lower EEG power and coherence, except for 
a higher effective connectivity, in inter-ictal patients (p < .05). Compare to data 
obtained from the inter-ictal group, EEG power and coherence were increased in the 
pre-ictal group, with the exception of a lower effective connectivity in fronto-occipital 
(p < .05).Results revealed that Inter-ictal and ictal patients had decreased EEG power 
and coherence relative to healthy controls, were "normalized" in the pre-ictal or post-
ictal groups. 
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  Derosier F, Sheftell F, Silberstein (2004) Conducted a study randomised 
double blind study to compare the efficacy of a sumatriptan and naproxen combination 
medication , a butalbital-containing combination medication, and placebo used to treat 
moderate to severe migraine headache, in united states, among 442 subjects involved 
and 3 attack in adult migraineurs met International Classification of Head ache 
Disorders, the majority of subjects were female (88%) with a mean age 43 years. 88% 
Subjects were butalbital use ; 68% had butalbital for more than 6 weeks; and 82% 
reported satisfaction with butalbital. A cross treatment groups, 28-29% of subjects took 
medication within 15 minutes of migraine onset, 34-37% of subjects took medication 
>15 minutes to 2 hours after onset, 32-36% of subjects took medication more than 2 
hours. Results were revealed sumRT/Nap was superior than the BCM medication with 
in 15 mts more effective in reducing migraine attack. 
  Kenneth Casey, MD (2003), conducted a study University of Michigan. School 
of Dentistry and Center for Human Growth and Development at the University of 
Michigan, utilized PET scans of the brain, and other measurements of brain activity and 
chemical composition to determine that dopamine levels demonstrate unusual patterns 
in migraineurs during an attack. In this study 8 individuals with migraine, and 8 as 
control without migraine. Measure dopamine levels and brain activity in each group 
during headache, migraine attacks, and non-attack state Decrease in dopamine levels 
for the migraine group, and only during a migraine attack, almost identical in both 
groups during the headache and non-attack state. while individuals with migraine were 
resting or sleeping during an attack, their brain experienced a small spike in dopamine 
levels leading to more nausea, vomiting and increased pain,  
Dodick D, Brandes J, Elkind A et al conducted a study to assess the efficacy, 
speed of onset and tolerability of the nasal spray formulation of zolmitriptan in migraine 
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treatment. multicentre, randomised, double-blind study involved 2122 patients age 
of18-65 years who had an diagnosis of migraine (according to International Headache 
Society criteria with or without aura. Patients were randomised to receive zolmitriptan 
5mg nasal spray or placebo to treat up to 2 migraine attacks within 15 minutes of 
headache pain becoming moderate or severe. After that post dose assessed at 2 hours, 
1 hour, 30 minutes and 15 minutes and the headache response rate at 2 hours post-dose 
was 66.2% for the zolmitriptan group, compared with 35.0% for the placebo group (p 
< 0.001). Zolmitriptan nasal spray also produced significantly higher headache 
response earlier time points assessed, starting as early as 15 minutes post-dose                   
(p < 0.001). Results revealed that significantly higher pain-free rates with zolmitriptan 
nasal spray, compared with placebo, from 15 minutes post dose (p < 0.005). 
 
2.2. Review Literature Related to Cold Pack Application 
Debbie B. from Los Angeles (2006) Conducted small clinical study at the 
University of California, San Diego Medical Center, 76% of migraine patients got 
relief, stating the ice therapy product tested, I.C.E. Down, reduced pain and throbbing. 
National Headache Foundation and the Mayo Clinic include cold compresses and ice 
packs among their recommendations to ease migraine symptoms. They makes for the 
most effective ice pack for headache. Cold application is a simple and inexpensive 
therapy which has been accepted as an effective non pharmacologic intervention for 
pain, decreases the inflammatory reaction and spasm.  
Lance et al. (2011) conducted a study the results of a new device, which 
employs cold, pressure and heat around the head. Fifteen out of twenty migraine 
patients and six out of seven tension headache patients involved in the study 
experienced some reduction in headache severity. , 9% of migraine patients reported 
that a cold wrap was almost completely effective, 26.5% moderately effective and 
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29.0% mildly effective. However to evaluate headache severity, As a result, cold 
therapy is still used clinically for migraine patients as an alternative or additive 
modality.  
Diamond S, Freitag FG (2006) conducted a cross over study at the Diamond 
Headache Clinic, Chicago, to the effectiveness of application of cold as an adjunctive 
therapy for acute headache. 90 outpatients were divided evenly into three groups 
according to headache type--migraine, cluster, and mixed and used the standard 
headache medication for two attacks, the standard medication plus application of cold 
with a reusable, frozen gel pack for two attacks. There was no significant difference in 
patient response to the gel pack by headache type. 71% of patients and 80%of those 
with migraine headache considered the pack effective; 52% reported an immediate 
decrease in pain, and 63% reported an overall decrease in pain. Results of Cold gel pack 
application effective in reducing the migraine head ache. 
Olavi, Nils (2003) conducted a study prospective randomized double blinded 
controlled compared the efficacy of a novel cold gel with that of a placebo gel in 
patients with a soft tissue injury at University hospital in Kuopio, Finland. 74 patients 
with sports-related soft tissue injury were randomly assigned to active cold gel or 
placebo gel groups. The gel was applied four times daily on the skin for 14 days. 
Clinical assessment was made after 7, 14, and 28 days with use of visual analog scale 
ratings and Subjects satisfaction with treatment was 71% in the cold gel group and 44% 
in the placebo group. Disability decreased significantly more rapidly in the cold gel 
group. The study reported that cold gel therapy provided an effective and safe treatment 
for soft tissue injuries. 
Kuzu N et al (2007) conducted a study among 63 patients to evaluate the effect 
of dry cold application on the occurrence of bruising and pain at injection site of 
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subcutaneous low molecular weight heparin at Brazil. Cold was applied 5min before 
injection in first group, after 5 min in second group while before and after 5min of the 
application in the third group and the fourth was kept as a control group. The pain 
intensity and indurations was measured at 48 and 72hrs. Results showed there is no 
significant difference in the incidence of bruising, however perception of pain was 
significantly reduced by cold application in the second group. 
 
2.3. Review Literature related to Effectiveness of Cold Pack Application on 
Migraine 
Vanderpol J, Bishop B, et al, (2015) conducted a study open label 
observational study to ascertain the effect of intranasal evaporative cooling an effective 
intervention used an acute 89migraine attack. 15 patients involved the International 
Classification of Headache Disorders (ICHD 2) diagnostic criteria for migraine were 
recruited. A total of 20 treatments were administered in 15 patients. pain score VAS 
Used. (based on a 0-10 visual analogue scale, [VAS].20 treatments, of intranasal 
evaporative cooling rendered to patients' pain and symptoms free immediately after 
treatment, in 8 of the treatments (40%), a further 10 treatments (50%) resulted in partial 
pain relief and partial symptoms relief. At 2 hours, 9 treatments (45%) full pain and 
symptoms relief, with a further 9 treatments (45%) resulting in partial pain relief. At 24 
hours, 10 treatments (50%) reporting pain freedom and 3 (15%) provided partial pain 
relief. 13 patients were (87%) significantly reduced pain and benefited from the 
treatment within 2 hours 
Friedman et al. (2011) conducted a study to efficacy of a non-invasive 
technique, intra-oral chilling, for acute migraine headache pain when compare with oral 
sumatriptan or placebo. Fifty participants involved in study, 9% of migraine patients 
reported that a cold therapy was almost completely effective, 26.5% moderately 
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effective and 29.0% mildly effective. However, they did not use an objective method 
to evaluate headache severity. As a result, cold therapy is still used clinically for 
migraine patients as an alternative or additive modality. In this study, we investigated 
the utility of cold therapy for migraine attacks approval to conduct the study for patients 
between 20 and 60 years.  
Adam S Sprouse-Blum, MD, (2013) Conducted a randomized, controlled, 
crossover clinical trial study utilizing an adjustable neoprene neck wrap that holds two 
freezable ice packs, the institutional review board conducted a studyin kenya. Frozen 
or non-frozen participants involved in the study, to evaluates this method of treatment 
in a novel location at the neck Wrap.101 participants met IHS ICHD-2 criteria for 
migraine and were enrolled in the study As such, 55 participants were analysed Of 
these, 25.5% (n=14) met IHS criteria for migraine with aura and the rest (74.5%) met 
criteria for migraine without aura. 85.5% of participants (n=47) were female. 
Participant ages varied from 19 to 64 with a mean age of 43.1 ± 11.4 years. Reported 
frequency of migraine attacks less than one per month with a median frequency of 5.5 
an interquartile range of 4.63 (25th percentile) and 28.75 (75th percentile). The frozen 
neck wrap was significantly more effective decreasing pain score, decrease in vascular 
permeability and a decrease in local nociceptive stimulation. 
John F. Rothrock, M.D., Conducted a study at University of California, San 
Diego (UCSD) Medical Center. A clinical study of I.C.E. DOWN was performed on 
25 patients with migraine and 25 patients with muscle tension headaches, or both, were 
Involved in the study. Only patients with a minimum of 10 headaches within 2 months 
study were used. Each patient was evaluated recent headache history, headache 
frequency, duration and intensity. All the patients were taking some form of medication 
for their headache and each agreed to stop their drug treatment for the duration of the 
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study. Each patient was supplied with the I.C.E.DOWN cold therapy head wrap and 
asked to use it in the event of a recurrence of a typical headache. Each patient was 
followed for a two-month period and at the end of that time an evaluation was done on 
each patient.73% of the patients improved since beginning the use of I.C.E. DOWN 
83% would prefer, I.C.E. DOWN instead of a drug. 80% would recommend I.C.E. 
DOWN to their friends or family. 76% stated I.C.E. DOWN reduced pain and 
throbbing. 66% stated I.C.E. DOWN lessened the severity of pain. 53% stated I.C.E. 
DOWN helped muscle spasms in the back of the neck. Results revealed that 
significantly reduced migraine head ache. 
Selekler HM, Erdogan Ms, Budak f (2004) Conducted a study to compare the 
prevalence and clinical characteristics of 'cold-induced headache' between migraine and 
episodic tension-type headache patients. 76 migraine and 38 episodic tension-type 
headache patients were included in the study. The pain occurrence period, its location 
and quality were recorded each patient felt pain in their head during the test procedure. 
Pain occur in 74% of migraine and 32% of 'tension-type headache' patients. Pain 
location was the temple in both groups, this rate was greater than twofold in migraine 
patients compare with episodic tension-type headache patients. Headache quality was 
throbbing in 71% of migraine patients, 8% of the episodic tension-type headache 
patients. Considering all the results, it seems that 'cold-stimulus headache' is not only 
more frequent in migraine patients, but also its location and quality differ from 'tension-
type headache'. 
Serap ulcer, Oslem Coskun (2006) Conducted a study Ankara training and 
research hospital open label non controlled study. A study involved 28 patients using 
cold therapy was administered to the by gel cap. Patients used this cap during their two 
migraine attacks. Before and after the cold therapy, headache severity was recorded by 
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using visual analogue scale (VAS). Patients used this cap after 25minutes in each 
application and recorded their VAS score just after the therapy and 25minutes, 1hr, 2hrs 
and 3hrs later, results revealed that Cold application alone may be effective in migraine 
attacks.  
 
2. 4) Review Literaure Related to Other Treatment for Migraine 
Timothy C. Hain MD. (2016) Conducted a study to Application of an ice pack 
and local scalp pressure are the most commonly used to evaluate non-pharmacological 
methods for temporary relief of migraine headache in south kenya. An elastic band 
secured the band was used to apply local pressure over the area of maximum pain in 25 
patients with migraine headache. 3 headaches were studied in each patient. The 23 
patients used the band in a total of 69 headaches. Pain relief was monitored for 30 
minutes at 10 minute intervals. 60 headaches (87%) were relieved. 9 headaches (13%) 
were not improved. 67 % of those who improved (40 headaches) relief of over 80%, 
25% percent (15 headaches) improved between 50–60% and 8% (5 headaches) 50% 
improvement. Results revealed that temporary relief of pain from mechanical 
compression of the scalp supports the possibility that the pain is reduced in migraine 
headache.  
Ravikiran Kisan, MU Sujan,  et al (2008) Conducted a randomized controlleds 
study to evaluate the efficacy of Yoga therapy to reduce the episode of head ache, at, 
denmark. Participants involved in study 60, coventional care 30, yoga with 
conventional care 30. Yoga practice session for 5 day a week for6 weeks along with 
conventional care. Clinical assessment and autonomic function test were done at the 
end of the intervention. At baseline headache intensity was 9.30 ± 1.15 and 8.70 ± 1.26 
in Group CC and Group Y respectively. After the end of 6 weeks intervention migraine 
patients reported headache intensity as 7.73 ± 1.23 in group CC and 2.03 ± 1.29 in 
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group Y. The yoga group has shown significant reduction in heart rate (P < 0.05) 
compared to group CC. Group Yoga has shown more reduction in head ache frequency. 
Dr Brendan Davies (2010) Conducted a clinical trial study to evaluate the 
Botox toxin A was used specifically for the treatment of chronic migraine the Medicines 
and Healthcare products Regulatory Agency (MHRA). Botox® has effective for any 
other headache type 1384 patients with chronic migraine, and randomised them to 
treatment with Botox or placebo. These patients were suffering on average 20 days of 
headache each month, of which 18 were moderate or severe. Those randomised to 
Botox received fixed-site, fixed dose injections every 12 weeks over 56 weeks. These 
injections covered seven specific areas of the head and neck, with a total dose of 
between 155-195 units. At six months, after two cycles of treatment, those treated with 
Botox had on average eight less days of headache each month. After 12 months, 70% 
of those treated had ≤50% the number of headaches that they had done originally. Botox 
was well-tolerated. Botulinum toxin has been to reduce Migraine head ache, including 
cervical dystonia, neuropathic pain, lower back pain, spasticity, myofascial pain, and 
bladder pain. 
Kathryn M Rexrode (2009) Conducted a randomized study in Denmark to 
evaluate the effectiveness of foot refloxology in migraine. Twenty migraine headache 
sufferers received 240 reflexology treatments with an average of 12 sessions per patient 
for 2 months. Nine (45%) of the participants reported no longer having headaches, 6 
(30%) reported considerable improvement in their condition, 2 (10%) stated they felt 
little better and 3 (15%) reported no improvement. 
Younes Jahangiri Noudeh, MD, et al (2003) Conducted a clinical study to 
evaluate the non pharmacological techniques reducing the migraine head ache, in united 
states. 10 male patients (mean age was 32.0 ± 10.59 years) with acute onset of a 
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migraine headache according to IHS-2004 diagnostic criteria were involved in the 
study. Neck and upper thoracic spine massage and manipulation technique was 
performed. Headache pain intensity was scored before and after the intervention by 
means of a visual analog scale: Headache pain intensity was significantly reduced 
compared to the pretreatment values (1.85 ± 1.11 vs. 5.80 ± 2.25, p = .005). As a 
percentage, this represents a mean pain reduction of 68.77% ± 18.56 and all of the 
patients reported satisfaction with the intervention cervical and upper thoracic massage 
and manipulation technique could reduce the headache attack pain intensity.  
 
2.5 Conceptual Frame Work 
Conceptual frame work represents a less formal attempt at organizing 
phenomena than theories. It refers to the interrelated concepts or abstractions that are 
assembled together in some rationale scheme by virtue of their relevance to a common 
theme. 
 
Thoerist information 
Theorist Imogene king born in 1923.Bachelor in science of nursing from st. 
Louis University in 1948.Master of science in nursing from st. Louis University in 
1957, Doctorate from teachers college, Columbia University. Theory describes a 
dynamic, interpersonal relationship in which a person grows and develops to attain 
certain life goals. 
  The present study was intended to determine the effectiveness of cold pack 
application in migraine headache attacks among male, and female. The conceptual 
frame work of the present study was developed by the investigator adopted Modified 
Imogine King’s Goal Attainment Theory (1981) based on the personal and 
interpersonal systems including interaction, perception, judgment, communication and 
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transaction. The investigator adopted goal attainment as a basic theory for conceptual 
framework, which is aimed at effectiveness of cold pack application on acute episodic 
migraine patients will reduce the level of pain. This involves interaction between the 
researcher and the clients attending outpatient department of neuro medicine at 
Government Rajaji Hospital, Madurai.  
 
Six major concepts describe the phenomena 
Perception 
Perception is a basic concept, that occurs through the use of both sensory “ and 
Intellectual” tools. Perceptual congruence is an Important element in nurse –client 
interaction and is the first step in Mutual goal setting. 
In present study, the investigator perceives that migraineur, are having moderate 
to severe head ache during head ache attacks that may affect their daily living and 
performance level. Migraineur perceive that there is need to control the pain intensity, 
frequency of occurrence so as to improve their well being 
  
Communication 
Communication is a process where by information is given one person to 
another either directly or indirectly. The vehicle by which human relations are 
developed and maintained encompasses intrapersonal, interpersonal, verbal and 
nonverbal communication. 
 
Interaction 
Interactions are the acts of two or more person in mutual presence, a sequence 
of verbal and non-verbal behaviors that are goal directed. 
In this study, the investigators communicates with migraine clients and get their 
co-operation and select the willing eligible population.  
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Action 
Action is sequence of behaviors involving mental and physical action. This 
refers to the changes that have to be achieved. 
The researcher action is to provide cold pack application on acute episodic pain 
on migraine clients to reduce the the level of pain, frequency of attack and clients 
receive it. 
 
Reaction 
Which is considered as included in the sequence of behaviors described in 
action. In addition King’s discussed about- goal, domain and functions of care provider. 
Reaction helps in setting a mutual goal. 
In this study the researcher and migraine clients to set a mutual goal. Here the 
mutual goal is reduction of pain by appling cold pack intervention. 
 
Transaction 
Transaction is process of interaction in which human beings communicate with 
the environment to achieve goals that are valued; goal directed human behaviors. In 
transaction two individuals mutually identify goal and the means to achieve it. 
Here the researchers goal is achievement of the reduction in level of pain and 
evaluate the effectiveness of Cold pack intervention on migraine Measured by 
Numerical Rating scale. 
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CHAPTER-III 
RESEARCH METHODOLOGY 
 
Research methodology is a way we systematically solve the research problems. 
Designing a research involves the development of plan or strategy that will guide the 
collection and analysis of the data. The present study is designed to evaluate the 
effectiveness of Cold pack application on acute episodic Pain among patients with 
migraine in OPD. Methodology is an investigation and the ways of obtaining, 
organizing and analyzing data. This chapter deals with the description of the methods 
and different steps used for collecting and organizing the data. It includes the research 
approach, research design, and setting of the study, sample and sampling technique. It 
further deals with development and description of tool, procedure for data collection 
and plan for data analysis.  
 
3.1 Research approach 
  The research approach tells the researcher from where the data to be collected, 
what to collect ,how to collect and how to analyze them. It also suggests a possible 
conclusion and help the researcher in answering specific research questions in an 
accurate and efficient way. 
In this study, Quantitative research approach was adopted 
 
3.2 Research design 
  The research design used for this study is -True Experimental design - pre test 
post test only design. 
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O1- Pretest level of acute episodic pain score 
X- Intervention of Cold pack application 20 minutes, two times with half an hour 
interval in the Morning.  
O2- Post test level of acute episodic pain score 
R- Randamization 
 
3.3 Research variables 
Independent variable: Cold pack application  
Dependent variable: level of acute episodic pain  
Socio demographic variables - Age, Gender, Religion, Education, 
Occupation, residence Income 
Clinical Variables –Dietary triggers, frequency of head ache, How long head ache will 
lost , prescribed medications ,working days missed due to head ache, other head ache 
triggers, location, migraine peak, pulsating quality, fatigue, Photophobia, Phonophobia, 
Vomiting, sleep quality, Radiological Investigations 
 
3.4 Research Setting  
  The study was conducted in outpatient department of Neuro Medicine at, 
Government Rajaji Hospital Madurai. It is a 3106 bedded Multy specialty, Medical college 
attached Hospital and it provides comprehensive care to all .Government Medical college 
Hospital has all speciality departments .The Hospital has separate Neuro medicine 
Outpatient department is attending patients 250to 400 per day, 8to 10 patients of migraine 
per day, an annual census of 2600 patients have migraine. 
GROUP PRETEST INTERVENTION POSTTEST 
Experimental group  O1  X  O2 
Control group  O1   O2 
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3.5 Population 
Target population 
  The target population were migraine patients. 
Accessible population 
  The accessible population were acute episodic pain of migraine patients both male 
and female in out patient department of Neuro Medicine at Government Rajaji Hospital, 
Madurai. 
 
3.6 Sample 
  Migraine Patients in Neuro Outpatient department at Govt Rajaji Hospital, Madurai 
and those who met the inclusion criteria 
 
3.7 Sampling technique 
  Samples for this study were selected by Simple random sampling technique. 
 
3.8 Sample size 
The sample size was 60, experimental group -30, control group-30 
 
3.9 Criteria for sample selection 
Inclusion criteria 
i. Clients with Acute episodic pain 
ii. Clients those Who are under treatment of propranolol, Amitriptyline 
 
Exclusion criteria 
i.  Menstrual migraine 
ii.  Pregnancy 
iii.  vertigo 
iv. Clients with other Systemic diseases 
v. sinusitis 
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3.10 Research tool and technique 
  The technique used in this study was structured interview method. 
 
Description of tool 
  The tool consist of two sections 
Section I Socio demographic variables and clinical Variables 
Section II Pain scale-Numerical rating scale, International Headache Society 
Criteria  
 
Section I 
It consist of socio demographic variables such as age, religion, educational status, 
occupation, monthly family income, place of domicile, frequency of head ache, how long 
head ache will last, number of working days missed /3 month, dietary triggers of migraine, 
other head ache triggers, any medication used for migraine, peak time of pain, location of 
head ache, pulsating quality, photophobia, phonophobia, vomiting, sleep, Investigations.  
 
Section II 
Pain scale-Numerical rating scale, International head ache society criteria, used 
for assessing Migraine patients. 
 
Scoring procedure 
Section I Socio demographic and clinical variables no scoring 
Section II Migraine Head ache scored by pain numerical rating scale Migraine Head ache 
scored, by pain numerical Rating scale, ranging from 0-10 
 0- No pain 
 1-3 Mild pain  
 4-6 Moderate pain 
 7-10 Severe pain 
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Level of pain Score 
No pain 0 
Mild pain 1-3 
Moderate pain 4-6 
Severe pain 7-10 
 
Testing of the tool  
3.11 Content validity 
The content validity of the tool with evaluation criteria checklist was submitted 
to one experts in the field of Neuro Medicine and three experts in Medical surgical 
Nursing for the opinion of the items in the tool. There was agreement by the experts 
and minimal modification were made in socio demographic variables and clinical 
variables based on their suggestions. Tool was translated in to Tamil to confirm 
language validity. 
 
3.12 Reliability 
The Reliability of an instrument is the degree of consistency with which it 
measures the attribute and it is supposed to be measuring over a period of time. The 
tool was a standardized one which underwent test retest for reliability. Pain numerical 
rating scale has been used on two different occasions and the reliability has been 
estimated using the karl pearson’s correlation coefficient formula, that is Hence the tool 
is considered as reliable and used in this study. 
 
3.13 Pilot study 
Pilot study conducted in Neuro medicine out patient department in Govt Rajaji 
hospital Madurai from 6.3.17-12.3.17 to test the feasibility of setting, samples, 
relevance and practicability of the intervention among subjects10 samples those who 
fulfill the inclusion criteria were chosen by using samples were randomly  assigned to 
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intervention group and control group by lottery method formal permission obtained 
from the head of the department of neuro medicine. Informed consent was obtained 
from the samples and data was collected pre assessment test level of acute episodic pain 
among migraine using pain rating scale. Cold pack intervention done two times half an 
hour interval, post test was done using same scale. After the pilot study Presentation as 
per the experts suggestion questionnaire 8 and 9 Merged into one question. The findings 
evidenced that there is significant statistical difference in pre test and post test scores 
on the level of pain reduction in migraine patients, the study tool was feasible and 
practicable to conduct the study. 
 
3.14 Ethical Consideration 
 This study was conducted after the approval from the ethics committee, Madurai 
Medical College, Madurai – 20. All the respondents were carefully informed about the 
purpose of the study and their part during the study and how the privacy was guarded. 
Confidentiality was ensured. Written permission was obtained from all participants. 
 
3.15 Data Collection Procedure 
  The researcher obtained formal permission from Ethical committee of Madurai 
Medical College, Madurai, and the study was conducted for a period of 6 weeks from 
20.3.17 to 30.4.17 in outpatient department of Neuro Medicine at, Government Rajaji 
Hospital Madurai. Rapport was established with migraine patients. After a brief 
introduction about the study, its purpose and Informed consent obtained from migraine 
patients. Based on inclusion criteria samples 60 selected by simple random sampling 
technique. Pretest data was collected by researcher using International Head ache 
Society criteria, and numerical Pain rating scale. Cold pack was wrapped in a small 
towel and place over on the patients fore head for 20 minutes, two times with half an 
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hour interval per day. The post test and at Pain level was assessed using Pain numerical 
rating scale and assessed the diagnostic criteria, and level of Pain Irrespectively.  
 
3.16 Plan for Data Analysis 
  The data analysis was done according to the objectives of the study. Both 
descriptive and inferential statistics were used. Socio demographic and clinical 
variables data were analyzed in frequency and percentage distribution. Mean and 
standard deviation were used to analyze the changes in the level of acute episodic pain 
among Migraine patients. Paired ‘t’ test, unpaired t test was used to evaluate the 
effectiveness of cold pack intervention on acute episodic pain . Chi-square test was used 
to determine the association of level of acute episodic pain with their selected socio 
demographic and clinical variables and to compare pre and post test pain level. Simple 
bar diagram, multiple bar diagram, and cylinderical diagram were used to represent the 
data p-value of ≤ 0.05 was considered statistically significant. 
 
3.17 Protection of human rights 
  The proposed study was conducted after the approval of Ethical committee of 
Madurai Medical College, Madurai. Informed Consent was obtained from the Migraine 
patients before starting the data collection. Confidentiality was maintained. The formal 
approval was obtained from the Head of the Department of Neuro Medicine. The name 
of the subjects was not disclosed at any time. Assurance was given that they can 
withdraw from the study at any time. The possible benefit of participating in the study 
was explained to the subjects and anonymity was maintained throughout the study. 
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SCHEMATIC REPRESENTATION OF METHODOLOGY 
 
 
 
 
. 
 
 
 
 
  
  
  
Accessible population - acute episodic pain of migraine patients coming in 
Outpatient department, Government Rajaji Hospital, Madurai-20 
Sample – Migraine patients in OPD GRH Madurai those who fulfill the inclusion 
criteria criteria 
Research approach – quantitative approach 
Research design – True experimental design (pre test – post test only design) 
Target population – all migraine patients 
Samples– Sample randomly assigned 
Sample size – 60 patients 
30 patients in experimental group 
group 
30 patients in control group 
group 
Pretest in both experimental and control group using pain numerical rating 
scale, IHS criteria 
Intervention (cold pack application twice half an hour interval)  
given in experimental group 
Post test in both experimental, and control group using pain numerical rating 
scale 
Analysis and interpretation (Descriptive and Inferential statistics) 
Dissemination of results. 
  
 
DATA ANALYSIS AND 
INTERPRETATION 
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CHAPTER IV 
DATA ANALYSIS AND INTERPRETATION 
 
Data analysis is a systematic organization and synthesis of research data and 
testing of research hypothesis using those data. Interpretation is the process of taking 
sense of the result and examining their implications. This chapter deals with the analysis 
and interpretation of data collected from 60 samples of patients With Migraine to 
evaluate the achievement of the objectives of the study. This study was done to evaluate 
the effectiveness of Cold pack application on Acute episodic pain among patients with 
migraine in OPD at Government Rajaji Hospital, Madurai. 
 
The data collected were interpreted under the following sections 
Section –I: Distribution of socio demographic variables and clinical variables among 
Patients With migraine. 
Section – II: Description of level of acute episodic pain among patients with Migraine  
Section – III: Effectiveness of Cold pack application on acute episodic pain among 
 Patients with Migraine. 
Section – IV: Association between the level of Acute episodic pain among patients 
with Migraine and their selected socio demographic variables and clinical variables. 
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Section I 
Distribution of socio demographic variables and clinical variables among 
With Migraine patients 
Table – I 
Frequency and percentage distribution of socio demographic variable among 
patients with Migraine 
 
Demographic variables 
Group 
Experiment(n=30) Control(n=30) 
f % f % 
Age 21-30 years 9 30.0% 14 46.7% 
  31-40 years 11 36.6% 9 30.0% 
  41-50 years 8 26.7% 5 16.6% 
  > 50 years 2 6.7% 2 6.7% 
Gender Male 2 6.7% 4 13.3% 
  Female 28 93.3% 26 86.7% 
Religion Hindu 27 90.0% 28 93.4% 
  Christian 2 6.7% 1 3.3% 
  Muslim 1 3.3% 1 3.3% 
Education Primary education 10 33.3% 8 26.7% 
  Secondary education 11 36.7% 7 23.3% 
  Higher secondary 3 10.0% 8 26.7% 
  Graduate 3 10.0% 3 10.0% 
  No formal education 3 10.0% 4 13.3% 
Occupation Company 6 20.0% 5 16.7% 
  Daily wages 4 13.3% 8 26.7% 
  Business 4 13.3% 3 10.0% 
  Housewife 13 43.4% 10 33.3% 
  Unemployed 3 10.0% 4 13.3% 
Residence Rural 12 40.0% 17 56.7% 
  Urban 18 60.0% 13 43.3% 
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The above table reveals the socio demographic variables data among Patients 
with migraine, such as Age, Gender, Religion, Education, Occupation, and Residence. 
Regarding Age, Majority of patients with migraine in Experimental group 11(36.6%) 
between 31-40 years, 9 (30.0%), were Between 21- 30 years, 8(26.7%) between 41- 50 
years and remaining 2(6,7%) were more than 50 years. In control group Majority of 
patients 14(46.7%) between 21-30 years,9(30.0%)were between31-40 years ,5(16.6%) 
were between 41-50 years , and 2(6.7%) were more than 50 years. 
  With regard to Gender, majority of patients with migraine in experimental group 
28 (93.3%) were Females and remaining 2 (6.7%) were males, in control group 26(86.7 
%) were females and remaining 4(13.3%) were males. 
  While comparing, Religion majority of patients with migraine in experimental 
group 27(90.0 %) were belonged to Hindu, 2(6.7%) were belonged to Christian, 
1(3.3%) were belonged to Muslim. In control group 28(93.4%) were belonged to 
Hindu, 1(3.3%) were belonged to Christian, and 1(3.3%) were belonged to Muslim. 
  According to Education, majority of patients with migraine in experimental 
group 11(36.7%) were attained Secondary Education, 10(33.3%) were Primary 
Education, 3(10.0%) were Higher Secondary Education, Graduate, and No formal 
education. In control group 8(26.7%) were attained Higher Secondary Education and 
Primary Education, 7(23.3%) were Secondary Education, 4(13.3%) had No formal 
education, and the remaining 3(10.0%) had Graduates. 
  By seeing Occupation majority of patients with Migraine in Experimental group 
13(43.4%) were House wife, 6(20.0%) were working in Company, 4(13.3%) were 
Daily wages, 4(13.3%) were Business and 3(10.0%) were un employed. In control 
group 10(33.3%) were House wife, 8(26.7%) were Daily wages, 5(16.7%) were 
working in Company, 4(13/3%) were Unemployed, 3(10.0%) were Business. 
  While discussing Residence, majority of Patients with Migraine in 
Experimental group 18(60.0%) were Urban people, 12(40.0%) were rural people. In 
control group 17(56.7%) were rural people, 13(43.3%) were Urban people. 
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Figure : 2.  Percentage distribution of subjects according to their age in both 
experimental and control group 
 
The above clustered bar diagram reveals that the majority of the study 
participants (36.6%) in experimental group is 31-40 Years and (46.7%) in control group 
is between 21-30 years, (6.7%%) in minor both experimental and control group is more 
than >50years. 
 
 
 
 
 
0%
10%
20%
30%
40%
50%
60%
70%
21-30 years 31-40 years 41-50 years > 50  years
30.0%
36.6%
26.7%
6.7%
46.7%
30.0%
16.6%
6.7%
%
 o
f 
p
at
ie
n
ts
Age Distribution
Experiment
Control
39 
 
 
 
 
 
 
Figure : 3. Percentage distribution of gender among patients with migraine 
 
The above clustered cylindrical diagram reveals that the majority of the 
participants in experimental group, (93.3%) were female, (86.7%) were female in 
control group. In minor (6.7%) were male in experimental group and (13.3%) were 
male in control group. 
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Figure: 4. Percentage distribution of religion among patients with migraine 
  
The above clustered cylindrical diagram reveals that the majority of the 
participants in experimental group (90.0%) were hindu, in control group, (93.4%) were 
hindu, in experimental group (6.7%) were christian, in control group(3.3%),were 
Christian, (3.3%) were Muslim, both experimental & control group. 
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Table – 2 
Frequency and percentage distribution of Clinical variable among patients with 
Migraine 
Clinical variables 
Group 
Experiment 
(n=30) Control (n=30) 
f % f % 
Dietary triggers 
  
  
  
  
  
Cheese 14 46.7% 12 40.0% 
Citrus fruits 1 3.3% 1 3.3% 
Coffee 1 3.3% 1 3.3% 
Missed meal 3 10.0% 4 13.4% 
Ice cream 5 16.7% 6 20.0% 
None 6 20.0% 6 20.0% 
Frequency of head 
ache (in 
times/week) 
  
1 -2 times 21 70.0% 24 80.0% 
3 -4 times 
9 30.0% 6 20.0% 
How long the head 
ache will usually 
last(in hours) 
  
  
  
4 -10 21 70.0% 17 56.7% 
11 -17 1 3.4% 6 20.0% 
18 -24 4 13.3% 3 10.0% 
> 24 
4 13.3% 4 13.3% 
Medication used 
  
Yes 30 100% 30 100% 
No 0 0% 0 0% 
No. of work days 
missed 
  
  
  
1 to 2days /3month 6 20.0% 7 23.3% 
3 to 4days /3month 2 6.7% 1 3.3% 
>4days /3month 1 3.3% 2 6.7% 
None 
21 70.0% 20 66.7% 
Other triggers 
  
  
  
  
  
  
  
Stressful event 15 50.0% 13 43.3% 
Exposure to sunlight 4 13.3% 2 6.7% 
Strong odor 3 10.0% 1 3.3% 
Loud noise 2 6.7% 4 13.3% 
Exposure to bright light 1 3.3% 1 3.3% 
Fatigue 1 3.3% 1 3.3% 
Travel 1 3.3% 4 13.3% 
Sleep disturbances 3 10.0% 4 13.3% 
Which time peak 
  
  
  
Early morning 13 43.3% 9 30.0% 
Afternoon 11 36.7% 11 36.7% 
Evening 3 10.0% 9 30.0% 
Night 3 10.0% 1 3.3% 
Location of Head 
ache 
  
  
Once side 20 66.7% 23 76.7% 
Both side 2 6.7% 2 6.7% 
Back of the head , along 
with neck 
8 26.6% 5 16.6% 
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Pulsating quality 
  
Yes 28 93.3% 25 83.3% 
No 2 6.7% 5 16.7% 
Fatigue 
  
Yes 27 90.0% 27 90.0% 
No 3 10.0% 3 10.0% 
Photophobia 
  
Yes 26 86.7% 24 80.0% 
No 4 13.3% 6 20.0% 
Phonophobia 
  
Yes 25 83.3% 26 86.7% 
No 5 16.7% 4 13.3% 
Vomiting 
  
Yes 18 60.0% 16 53.3% 
No 12 40.0% 14 46.7% 
Sleep 
  
Sleep 
disturbance 
22 73.3% 25 83.3% 
Normal 
sleep 
8 26.7% 5 16.7% 
Have you underwent 
Investigations 
  
Yes 23 76.7% 28 93.3% 
No 
7 23.3% 2 6.7% 
 
  The above table reveals that Based on the Dietary triggers, Majority of patients 
with migraine In experimental group 14(46.7%) were taking Cheese, 6(20.0%) had 
None of dietary trigger, 5(16.7%) had Ice Cream, 3(10.0%) had missed meal and 
remaining 1(3.3%) had Citrus fruits, and coffee. In Control group 12(40.0%) had 
Cheese, 6(20.0%) had Ice Cream and none of dietary trigger, 4(13.4%) were missed 
meal, 1(3.3%) had Citrus fruits and coffee. 
  Regarding the Frequency of Head ache, majority of the Patients with Migraine 
In Experimental group 21(70.0%) had 1- 2 times attack per week, 24(80.0%) were 1-2 
times per week in control group. In minor 24(30.0%) had 3- 4 times attack per week, 
6(20.0%) were 3-4 times per week in control group. 
  According to the How long Head Ache will Lost (in hours), majority of the 
Patients with migraine In experimental group 21(70.0%) had pain 4-10 Hours, 
4(13.3%) had pain 18-24 Hours, and >24 Hours and remaining 1(3.4%) had 11-17 
Hours. In Control group 17(56.7%) had pain 4-10 Hours, 6(20.0%) had 11-17 Hours, 
and remaining 4(13.3%) had >24 Hours, 3(10.0%) had 18-24 Hours. 
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  Discussing Medication used, majority of the Patients with Migraine 30( 100%) 
had medicine both experiment and control group and (0%) none of them with out 
medicine.  
  While assessing on No of working days Missed, majority of the Patients with 
migraine  In experimental group 21(70.0%) None of them absent, 6(20.0%) had 1-2 
days missed/3 month, 2(6.7%) had 3-4 days missed/3 month, 1(3.3%) had >4 days 
missed/3 month. In Control group 20(66.7%) had None of them absent, 7(23.3%) had1-
2 days missed/3 month, 2(6.7%) had >4 days missed/3 month and remaining 1(3.3%) 
had 3-4 days missed/3 month. 
  Discussing the other triggers, majority of the Patients with Migraine In 
experimental group 15(50.0%) had Stressful event, 4(13.3%) had Exposure to sunlight, 
3(10.0%) had Strong Odour and Sleep disturbances, 2(6.7%) had Loud noice, 1(3.3%) 
had exposure to Bright light, Fatigue, and Travel. In Control group 13(43.3.%) had 
Stressful event, 4(13.3.%) had Loud noise, Sleep disturbances, and Travel, 2(6.7%) had 
Exposure to sun light, 1(3.3%)had exposure to Bright light, Strong Odour and Fatigue. 
 Based on Which time pain in Peak majority of the Patients with Migraine In 
experimental group 13(43.3%) had pain in early morning, 11(36.7%) had pain in after 
noon, 3(10.0%) had pain in evening and night. In control group 11(36.7%) had pain in 
afternoon, 9(30.0%) had pain in early morning and evening,1(3.3%) had pain in Night. 
 Discussing the Location of Head ache majority of the Patients with Migraine In 
experimental group 20(66.7%) had pain One side, 8(26.6%) had pain back of the head 
along with neck, 2(6.7%) had both side. In Control group 23(76.7%) had pain in One 
side, 5(16.6%) had pain in Back of the head along with neck, 2(6.7%) had pain in both 
side. 
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 Assesssing to Pulsating quality pain majority of the Patients with migraine In 
experimental group 28(93.3%) had pulsating pain Remaining 2(6.7%) none of them 
had pulsating pain. In Control group 25(83.3%) had pulsating pain, remaining 5(16.7%) 
none of them had pulsating pain. 
  Based on Fatigue majority of the Patients with migraine In experimental group 
27(90.0%) had fatigue 3(10.0%) none of them had fatigue both experimental and 
control group . In control group 27(90.0%) had fatigue.  
  Assessing on Photophobia majority of the Patients with migraine In 
experimental group 26(86.7%) had photophobia, 4(13.3%) none of them had 
photophobia. In control group 24(80.0%) had photophobia, 6 (20.0%) none of them had 
photophobia. 
  Collecting data on Phono phobia majority of the Patients with migraine In 
experimental group 25(83.3%) had phonophobia, 5(16.7%) none of them had 
phonophobia. In control group 26((86.7%) had phonophobia 4(13. 3%) none of them 
had phonophobia.  
  While assessing the vomiting majority of the Patients with Migraine In 
Experimental group 18(60.0%) had vomiting, 12(40.0%) none of them had vomiting. 
In control group 16((53.3%) had vomiting. 14(46.7%) none of them had vomiting. 
  Discussing to Sleep disturbance majority of the Patients with migraine In 
experimental group 22(73.3%) had sleep disturbance, 8(26.7%) had normal sleep. In 
control group 25((83.3%) had sleep disturbance, 5(16.7%) had normal Sleep. 
  Based on Have you underwent radiological investigations majority of the 
Patients with Migraine In Experimental group 23(76.7%) were investigated, 7(23.3%) 
none of them had investigated. In control group 28((93.3%) were investigated, 2(6.7%.) 
none of them had investigated. 
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Figure: 5. Percentage distribution of Dietary triggers among Migraine patients 
 
The above diagram Shows that Based on the Dietary triggers, majority of 
patients with migraine in experimental group 14(46.7%) were taking Cheese and 
remaining 1(3.3%) had Citrus fruits, and coffee. In Control group 12(40.0%) had taking 
Cheese, 1(3.3%) had Citrus fruits and coffees. 
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Figure : 6. Percentage distribution of Frequency of head ache among Migraine 
patients 
 
  The Above cylindrical diagram revealed that Frequency of Head ache, 
majority of the Patients with migraine In experimental group 21(70.0%) had 1- 2 times 
attack per week, 24(80.0%) were 1-2 times per week in control group. In minor 
24(30.0%) had 3- 4 times attack per week, 6(20.0%) were 3-4 times per week in control 
group. 
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Figure : 7.  Percentage distribution of other triggers among Migraine patients 
 
The above clustered diagram shows other triggers, majority of the Patients 
with Migraine In experimental group 15(50.0%) had Stressful event, 4(13.3%) had 
Exposure to sunlight, 3(10.0%) had Strong Odour and Sleep disturbances, 2(6.7%) had 
Loud noice, 1(3.3%) had exposure to Bright light, Fatigue, and Travel. In Control group 
13(43.3.%) had Stressful event, 4(13.3.%) had Loud noise, Sleep disturbances, and 
Travel, 2(6.7%) had Exposure to sun light, 1(3.3%)had exposure to Bright light, Strong 
Odour, and Fatigue. 
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Figure: 8. Percentage distribution of pulsating quality of pain among Migraine 
patient 
  The above cylindrical bar diagram revealed that Assesssing to Pulsating 
quality pain majority of the Patients with migraine In experimental group 28(93.3%) 
had pulsating pain Remaining 2(6.7% ) none of them had pulsating pain. In Control 
group 25(83.3%) had pulsating pain, remaining 5(16.7%) none of them had pulsating 
pain. 
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Figure : 9. Percentage distribution of photophobia among Migraine patients 
 
The above Bar diagram reveals that Assessing Photophobia majority of the 
Patients with migraine In experimental group 26(86.7%) had photophobia, 4(13.3%) 
non of them had photophobia. In control group 24(80.0%) had photophobia, 6 (20.0%) 
none of them had photophobia.  
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Section – II 
Description of pretest level of acute episodic pain among patients with 
Migraine 
Table-3 
Frequency and percentage distribution of pre test level of Pain Score among 
patients with Migraine 
Level of pain score 
TEST 
Experiment Control 
f % f % 
No pain 0 0.0% 0 0.0% 
Mild pain 0 0.0% 0 0.0% 
Moderate pain 16 53.3% 19 63.3% 
Severe pain 14 46.7% 11 36.7% 
 TOTAL  30 100%  30 100% 
 
  The above table states that in the pre test assessment of majority of the Patients 
with Migraine in Experimental group 16(53.3%) had moderate level of 
Pain,14(46.7%)had Severe level of pain, none of them had no pain and Mild pain Score. 
In Control group 19(63.3%) of the patients had moderate level of pain score and                    
11( 36.7%) of the patients had severe Level of pain, none of them had no Pain and Mild 
Pain. 
 
. 
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Table 4: 
Comparison of pretest pain score between experiment and control group 
 
Group f 
Mean pain 
score 
Std. Deviation Mean Difference 
Student 
independent 
t-test 
Experiment 30 6.60 0.77 
0.20 
t=0.80 P=0.43 
DF=58 
Not 
significant 
Control 30 6.40 1.13 
 
P>0.05 not significant 
 
The above table 4 shows that in experimental group Pretest level of pain score 
Mean 6.60, in Control group pretest level of pain score Mean 6.40, so the Mean 
difference is 0.20, this difference is small and it is not statistically significant. Statistical 
significance was calculated using student independent t-test-0.80, p-value=0.43. 
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Table 5 
Posttest level of pain score 
Level of pain score 
TEST 
Experiment Control 
f % f % 
No pain 17 56.7% 3 10.0% 
Mild pain 13 43.3% 19 63.3% 
Moderate pain 0 0.0% 8 26.7% 
Severe pain 0 0.0% 0 0.0% 
 TOTAL 30 100%  30 100% 
 
Fig DF= Degrees of Freedom*** very high significant at P≤0.001 
 
 
  The above table shows that in the post test majority of the Patients with Migraine 
in Experimental group 17 (56.7%) had No Pain,13(43.3%)had Mild level of pain, none 
of the patients had Moderate, and Severe pain score.In Control group 19( 63.3%) of the 
patients had mild level of pain score and 8( 26.7%) of the patients had Moderate Level 
of pain, 3(10.0%) of the patients had no Pain ,and none of the patients had severe Pain. 
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Table 6 
Comparison of posttest pain score between experiment and control group 
 
Group f 
Mean pain 
score 
Std. 
Deviation 
Mean 
Difference 
Student 
independent t-test 
Experiment 30 1.13 1.43 
2.04 
t=6.01 P=1.00 
DF=58 NS Control 30 3.17 1.17 
 
Significant at P≤0.05 S=significant 
 
 
  The above table shows that in experimental group Posttest level of pain score 
Mean 1.13, in Control group posttest level of pain score Mean 3.17, so the Mean 
difference is 2.04, this difference is Large and it is statistically significant. Statistical 
significance was calculated using student independent t-test=6.01, P=1.00 not 
significant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
54 
 
Table 7 
COMPARISON OF OVERALL PRE AND POSTTEST PAIN SCORE 
 
  
No. of 
patients 
pain score 
Mean ± 
SD 
Mean 
Difference 
Student’s paired 
t-test 
Experiment  Pre-test 30 6.60± 0.77 5.47 t=22.47 
P=0.001*** 
 DF =29 
significant 
Post-test 30 1.13±1.43 
Control Pre-test 30 6.40± 1.13 3.23 t=10.71 
P=0.001*** 
 DF =29 
significant 
Post-test 30 3.17±1.17 
 
DF= Degrees of Freedom *** very high significant at P≤0.001 
 
 
  The above table 7 shows that in experimental group Pretest and Posttest level 
of pain score Mean 6.60 and1.13, so the difference is 5.47. The difference between 
pretest and posttest score is large and it is statistically significant. The effectiveness of 
cold pack application along with medication on acute episodic pain of migraine patients 
shows that effective pain reduction in experimental group obtained t- value in post test 
is 22.47 at p value ≤0.001 Level of significance. 
  In Control group pretest and posttest level of pain score Mean 6.40and 3.17, so 
the Mean difference is 3.23, the difference between pretest and posttest score is large 
and it is statistically significant. The effectiveness of with medication, without 
intervention on acute episodic pain of migraine patients in Control group, obtained                  
t- value in posttest is 10.71 at p value ≤0.001 Level of significance. 
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Figure : 10.  Comparison of mean value of pretest and posttest level of pain 
among patients with experimental and control group 
 
The above cylindrical diagram depicts that the Cold pack intervention score 
between pretest and posttest, in pretest mean is 6.60, and posttest mean is 1.13 in 
experiment group, where as control group 6.40 is pretest level of mean and 3.17 is 
posttest level of mean score.  
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Table 8 
Percentage of pain reduction score among experimental & control group 
 
  
Max 
score 
Pain score  
Mean ± 
SD 
Mean Difference 
in pain score with 
95% Confidence 
interval 
Percentage of 
pain reduction 
score with 95% 
Confidence 
interval 
Experiment 
Pretest 10 6.60± 0.77 
5.47(4.97 -5.96) 
54.7% (49.7% –
59.6%) Posttest 10 1.13±1.43 
Control 
Pretest 10 6.40± 1.13 
3.23(2.62 -3.85) 
32.3% (26.2% –
38.5%) Posttest 10 3.17±1.17 
  
The above table 8 Shows that the effectiveness of cold pack application on acute 
episodic pain In experimental group had pretest and posttest obtained mean value 
54.7% pain reduction and in control group had 32.3% pain reduction with out 
intervention, so the d ifferences between pretest and posttest score was analyzed using 
mean difference with 95% confidence interval and proportion with 95% Confidence 
interval. This 22.4% Reduction of pain score difference shows the effectiveness of 
study. The cold pack intervention is more effective in reduction of pain in experimental 
group, than the control group.  
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Figure : 11. Percentage distribution of pain reduction on migraine patients after 
cold application 
The above cylindrical diagram depicts that after cold pack application among 
patients with migraine pain reduction score 54.7% in experiment group, 32.3%in 
control group The difference between pretest, posttest score is 22.4%. pain reduction 
score shows the study is effective.  
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Table 9 
Association between pretest level of pain In Experimental group with 
demographic variables. 
Demographic variables 
 
Pretest level of pain 
n Chi square test Moderate Severe 
f % f % 
Age 
  
  
  
21-30 years 5 55.6% 4 44.4% 9 2=2.07 P=0.55 
DF=3 NS 31-40 years 5 45.5% 6 54.5% 11 
41-50 years 4 50.0% 4 50.0% 8 
> 50 years 2 100.0%     2 
Gender 
  
Male 2 100.0%     2 2=1.87 P=0.17 
DF=1 NS Female 14 50.0% 14 50.0% 28 
Religion 
  
  
Hindu 15 55.6% 12 44.4% 27 2=1.20 P=0.55 
DF=2 NS Christian 1 50.0% 1 50.0% 2 
Muslim     1 100.0% 1 
Education 
  
  
  
  
Primary 
education 
6 60.0% 4 40.0% 10 
2=6.72 P=0.15 
DF=4 NS 
Secondary 
education 
6 54.5% 5 45.5% 11 
Higher 
secondary 
3 100.0%     3 
Graduate 1 33.3% 2 66.7% 3 
No formal 
education 
    3 100.0% 3 
Occupation 
  
  
  
  
Company 4 66.7% 2 33.3% 6 2=4.63 P=0.32 
DF=4 NS Daily wages 2 50.0% 2 50.0% 4 
Business 3 75.0% 1 25.0% 4 
Housewife 7 53.8% 6 46.2% 13 
Unemployed     3 100.0% 3 
Residence 
  
Rural 6 50.0% 6 50.0% 12 2=0.10 P=0.76 
DF=1 NS Urban 10 55.6% 8 44.4% 18 
 
   
The above table shows the association between Pretest level of pain in 
Experimental group and Demographic variables. None of the variables are significantly 
associated with demographic variables. It was confirmed using chi square test. 
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Table 10 
Association between pretest level of pain in Experimental group with clinical 
variables 
Clinical variables 
 
pretest level of pain score 
n Chi square test Moderate Severe 
f  % f  % 
Dietary 
triggers 
  
  
  
  
  
Cheese 9 64.3% 5 35.7% 14 2=4.22 P=0.51 
DF=5 NS Citrus fruits 0  0.0%  1 100.0% 1 
Coffee 0  0.0%  1 100.0% 1 
Missed 
meal 
1 33.3% 2 66.7% 3 
Ice cream 2 40.0% 3 60.0% 5 
None 4 66.7% 2 33.3% 6 
Frequency of 
head ache 
  
1 -2 times 12 57.1% 9 42.9% 21 2=0.40 P=0.52 
DF=1 NS 3 -4 times 
4 44.4% 5 55.6% 9 
How long 
Head ache 
will Last 
  
  
  
4 -10 12 57.1% 9 42.9% 21 2=1.30 P=0.72 
DF=3 NS 11 -17 0  0.0%  1 100.0% 1 
18 -24 2 50.0% 2 50.0% 4 
> 24 
2 50.0% 2 50.0% 4 
 medication 
used 
  
Yes 16 53.3% 14 46.7% 30 2=0.00 P=1.00 
DF=1 NS No 
0 0% 0 0% 0 
No of work 
days missed 
  
  
  
1 to 2days 
/3month 
4 66.7% 2 33.3% 6 
2=1.58 P=0.66 
DF=3 NS 
3 to 4days 
/3month 
1 50.0% 1 50.0% 2 
>4days 
/3month 
1 100.0% 0  0.0%  1 
None 10 47.6% 11 52.4% 21 
Other triggers 
  
  
  
  
  
  
  
Stressful 
event 
8 53.3% 7 46.7% 15 
2=3.61 P=0.82 
DF=7 NS 
Exposure to 
sunlight 
2 50.0% 2 50.0% 4 
Strong odor 2 66.7% 1 33.3% 3 
Loud noise 1 50.0% 1 50.0% 2 
Exposure to 
bright light 
0  0.0%  1 100.0% 1 
Fatigue 0  0.0%  1 100.0% 1 
Travel 1 100.0% 0  0.0%  1 
Sleep 
disturbances 
2 66.7% 1 33.3% 3 
Which time 
peak 
Early 
morning 
5 38.5% 8 61.5% 13 
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Afternoon 8 72.7% 3 27.3% 11 2=3.51 P=0.32 
DF=3 NS Evening 2 66.7% 1 33.3% 3 
Night 1 33.3% 2 66.7% 3 
Location of 
H.A 
  
  
Once side 11 55.0% 9 45.0% 20 2=2.57P=0.27DF=2 
NS Both side 2 100.0% 0  0.0%  2 
Back of the 
head ,  
along with 
neck 
3 37.5% 5 62.5% 8 
Pulsating 
quality 
  
Yes 16 57.1% 12 42.9% 28 2=2.44 P=0.11 
DF=1 NS No 
0  0.0%  2 100.0% 2 
Fatigue 
  
Yes 15 55.6% 12 44.4% 27 2=0.53 P=0.46 
DF=1 NS No 1 33.3% 2 66.7% 3 
Photophobia 
  
Yes 13 50.0% 13 50.0% 26 2=0.87 P=0.35 
DF=1 NS No 3 75.0% 1 25.0% 4 
Phonophobia 
  
Yes 14 56.0% 11 44.0% 25 2=0.42 P=0.51 
DF=1 NS No 2 40.0% 3 60.0% 5 
Vomiting 
  
Yes 10 55.6% 8 44.4% 18 2=0.09 P=0.76 
DF=1 NS No 6 50.0% 6 50.0% 12 
Sleep 
  
Sleep 
disturbance 
13 59.1% 9 40.9% 
22 2=1.10 P=0.29 
DF=1 NS 
Normal 
sleep 
3 37.5% 5 62.5% 
8 
Investigations 
  
Yes 14 60.9% 9 39.1% 23 2=2.24 P=0.13 
DF=1 NS No 2 28.6% 5 71.4% 7 
 
  The above table shows the association between Pretest level of pain score in 
Experimental group and Clinical Variables. None of the variables are significantly 
associated with Clinical variables. It was confirmed using chi square test. 
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Table 11 
Association between posttest level of pain in Experimental with Demographic 
variables 
Demographic variables 
 
Posttest level of pain 
n Chi square test No pain Mild 
f  % f  % 
Age 
  
  
  
21-30 years 8 88.9% 1 11.1% 9 2=9.91 P=0.02* 
DF=3 S 31-40 years 7 63.6% 4 36.4% 11 
41-50 years 2 25.0% 6 75.0% 8 
> 50 years 0  0.0% 2 100.0% 2 
Gender 
  
Male 1 50.0% 1 50.0% 2 2=0.04 P=0.84 
DF=1 NS Female 16 57.1% 12 42.9% 28 
Religion 
  
  
Hindu 15 55.6% 12 44.4% 27 2=2.85 P=0.24 
DF=2 NS Christian 2 100.0% 0  0.0% 2 
Muslim 0  0.0% 1 100.0% 1 
Education 
  
  
  
  
Primary 
education 
6 60.0% 4 40.0% 10 
2=1.72 P=0.79 
DF=4 NS 
Secondary 
education 
7 63.6% 4 36.4% 11 
Higher 
secondary 
2 66.7% 1 33.3% 3 
Graduate 1 33.3% 2 66.7% 3 
No formal 
education 
1 33.3% 2 66.7% 3 
Occupation 
  
  
  
  
Company 2 33.3% 4 66.7% 6 2=5.25 P=0.26 
DF=4 NS Daily wages 2 50.0% 2 50.0% 4 
Business 4 100.0% 0  0.0% 4 
Housewife 8 61.5% 5 38.5% 13 
Unemployed 1 33.3% 2 66.7% 3 
Residence 
  
Rural 6 50.0% 6 50.0% 12 2=0.36 P=0.54 
DF=1 NS Urban 11 61.1% 7 38.9% 18 
 
 
The above table shows the association between Posttest level of pain in 
Experimental group with Demographic Variables. Age 21-30 years 88.9% had 
significant association of more pain reduction than others, chi square 9.91 p-value 0,02. 
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Figure: 12. Percentage distribution of association between the post test level of 
pain and demographic variables in experiment group 
The above Clinderical diagram depicts that association of post test level of pain 
in experimental group 88.9% had between 21-30years pain reduction than others. Chi 
square value=9.91, p-value=0.02 statistically significant. Frequency of head ache 
Patients 1-2 times in a week is 71.4% in experimental group chi square value=6.21,           
p-value=0.01, Vomiting 83.3% chi square value 5.79, p-value=0.02,in ,Normal sleep 
pattern87.5% had pain reduction chi square value=4.22, p-value =0.04.these variables 
are associated with posttest level of pain. 
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Table 12 
Association between posttest level of pain In Experiment with clinical variables 
Clinical variables 
 
posttest level of pain score 
n Chi square test No pain Mild 
f  % f  % 
Dietary 
triggers 
  
  
  
  
  
Cheese 
9 64.3% 5 35.7% 
1
4 
2=7.54 P=0.18 
DF=5 NS 
Citrus 
fruits 
    1 100.0% 1 
Coffee     1 100.0% 1 
Missed 
meal 
2 66.7% 1 33.3% 3 
Ice cream 1 20.0% 4 80.0% 5 
None 5 83.3% 1 16.7% 6 
Frequency 
of head ache 
(in 
times/week)  
1 -2 times 1
5 
71.4% 6 28.6% 
2
1 
2=6.21 P=0.01** 
DF=1 S 
3 -4 times 
2 22.2% 7 77.8% 9 
How long 
the head 
ache will 
usually 
last(in 
hours) 
 
4 -10 1
1 
52.4% 10 47.6% 
2
1 
2=4.59 P=0.20 
DF=3 NS 
11 -17     1 100.0% 1 
18 -24 
4 
100.0
% 
    4 
> 24 
2 50.0% 2 50.0% 4 
 Medication 
used 
  
Yes 1
6 
53.3% 14 46.7% 
3
0 
2=0.00P=1.00 
DF=1 NS 
No 0 0% 0 0%  
No of work 
days missed 
  
  
  
1 to 2days 
/3month 
4 66.7% 2 33.3% 6 
2=3.62 P=0.30 
DF=3 NS 
3 to 4days 
/3month 
    2 100.0% 2 
>4days 
/3month 
1 
100.0
% 
    1 
None 1
2 
57.1% 9 42.9% 
2
1 
Other 
triggers 
  
  
  
  
  
  
  
Stressful 
event 
7 46.7% 8 53.3% 
1
5 
2=5.97 P=0.54 
DF=7 NS 
Exposure 
to sunlight 
2 50.0% 2 50.0% 4 
Strong 
odor 
2 66.7% 1 33.3% 3 
Loud noise 1 50.0% 1 50.0% 2 
Exposure 
to bright 
light 
    1 100.0% 1 
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Fatigue 
1 
100.0
% 
    1 
Travel 
1 
100.0
% 
    1 
Sleep 
disturbanc
es 
3 
100.0
% 
    3 
Which time 
peak 
  
  
  
Early 
morning 
5 38.5% 8 61.5% 
1
3 
2=4.38 P=0.22 
DF=3 NS 
Afternoon 
7 63.6% 4 36.4% 
1
1 
Evening 
3 
100.0
% 
    3 
Night 2 66.7% 1 33.3% 3 
Location of 
H.A 
  
  
Once side 1
3 
65.0% 7 35.0% 
2
0 
2=5.36P=0.07DF
=2 NS 
Both side 
2 
100.0
% 
    2 
Back of 
the head , 
along with 
neck 
2 25.0% 6 75.0% 8 
Pulsating 
quality 
  
Yes 1
5 
53.6% 13 46.4% 
2
8 
2=1.63 P=0.20 
DF=1 NS 
No 
2 
100.0
% 
    2 
Fatigue 
  
Yes 1
7 
63.0% 10 37.0% 
2
7 
2=4.35 P=0.03 
DF=1 NS 
No     3 100.0% 3 
Photophobia 
  
Yes 1
5 
57.7% 11 42.3% 
2
6 
2=0.08 P=0.77 
DF=1 NS 
No 2 50.0% 2 50.0% 4 
Phonophobi
a 
  
Yes 
1
6 
64.0% 9 36.0% 
2
5 
2=3.28 P=0.07 
DF=1 NS 
Vomiting 
  
Yes 
7 
38.9
% 
1
1 
61.1
% 
1
8 
2=5.79 P=0.02* 
DF=1 S 
No 
10 
83.3
% 
2 
16.7
% 
1
2 
Sleep 
  
 Sleep 
disturbance 
10 
45.4
% 
1
2 
54.6
% 
2
2 
2=4.22 P=0.04* 
DF=1 S 
Normal sleep 
7 
87.5
% 
1 
12.5
% 
8 
Investigatio
ns 
  
Yes 
14 
60.9
% 
9 
39.1
% 
2
3 
2=0.70 P=0.40 
DF=1 NS 
No 
3 
42.9
% 
4 
57.1
% 
7 
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The above table shows the association between Posttest level of pain in 
experimental group with Clinical Variables. Frequency of head ache Patients 1-2 times 
in a week is 71.4% in experimental group chi square value=6.21, p-value=0.01, 
,Vomiting 83.3% chi square value 5.79,p-value=0.02,in ,Normal sleep pattern87.5% 
had pain reduction chi square value=4.22, p-value =0.04.these variables are associated 
with posttest level of pain. 
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Table 13 
Association between pretest level of pain in Control group with demographic 
variables 
 
Demographic variables 
Pretest level of pain score 
n Chi square test Moderate Severe 
f  % f  % 
Age 21-30 years 
9 64.3% 5 35.7% 14 
2=0.99 P=0.80 
DF=3 NS 
  31-40 years 5 55.6% 4 44.4% 9  
  41-50 years 4 80.0% 1 20.0% 5  
  > 50  years 1 50.0% 1 50.0% 2  
Gender Male 
3 75.0% 1 25.0% 4 
2=0.27 P=0.60 
DF=1 NS 
  Female 16 61.5% 10 38.5% 26  
Religion Hindu 
18 64.3% 10 35.7% 28 
2=2.31 P=0.31 
DF=2 NS 
  Christian     1 100.0% 1  
  Muslim 1 100.0%     1  
Education Primary  
education 
3 37.5% 5 62.5% 8 
2=3.21 P=0.52 
DF=4 NS 
  Secondary 
education 
5 71.4% 2 28.6% 7 
 
  Higher 
secondary 
6 75.0% 2 25.0% 8 
 
  Graduate 2 66.7% 1 33.3% 3  
  No formal 
education 
3 75.0% 1 25.0% 4 
 
Occupation Company 
4 80.0% 1 20.0% 5 
2=8.90 P=0.06 
DF=4 NS 
  Daily wages 4 50.0% 4 50.0% 8  
  Business     3 100.0% 3  
  Housewife 7 70.0% 3 30.0% 10  
  Unemployed 4 100.0%     4  
Residence Rural 
9 52.9% 8 47.1% 17 
2=1.82 P=0.17 
DF=1 NS 
  Urban 10 76.9% 3 23.1% 13  
 
 
The above table shows the association between Pretest level of pain in Control 
group with Demographic Variables. None of the Patients are significantly associated 
with demographic variables. It was confirmed by using chi square test. 
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Table 14 
Association between pretest level of pain in control group with clinical variables. 
 
Clinical variables 
 
Pretest level of pain score 
n 
Chi square 
test 
Moderate Severe 
f  % f  % 
Dietary 
triggers 
Cheese 
5 41.7% 7 58.3% 12 
2=7.75 
P=0.17 DF=5 
NS   Citrus fruits 1 100.0%     1 
  Coffee 1 100.0%     1 
  Missed meal 3 75.0% 1 25.0% 4 
  Ice cream 3 50.0% 3 50.0% 6 
  None 6 100.0%     6 
Frequency of 
head ache 
1 -2 times 
17 70.8% 7 29.2% 24 
2=2.90 
P=0.08 DF=1 
NS   3 -4 times 2 33.3% 4 66.7% 6 
How long H a  
will Last 
4 -10 
14 82.4% 3 17.6% 17 
2=6.44 
P=0.09 DF=3 
NS   11 -17 2 33.3% 4 66.7% 6 
  18 -24 1 33.3% 2 66.7% 3 
  > 24 2 50.0% 2 50.0% 4 
Any 
medication 
used 
Yes 
19 63.3% 11 36.7% 30 
2=0.00 
P=1.00 DF=1 
NS 
  No 0 .0%   0%  0 
No of work 
days missd 
1 to 2days 
/3month 
5 71.4% 2 28.6% 7 
2=4.25 
P=0.23 DF=3 
NS   3 to 4days 
/3month 
1 100.0%     1 
  >4days /3month     2 100.0% 2 
  None 13 65.0% 7 35.0% 20 
Other triggers Stressful event 11 84.6% 2 15.4% 13 2=9.79 
P=0.29 DF=6 
NS 
  Exposure to 
sunlight 
1 50.0% 1 50.0% 2 
  Strong odor     1 100.0% 1 
  Loud noise 1 25.0% 3 75.0% 4 
  Exposure to 
bright light 
    1 100.0% 1 
  Fatigue 1 100.0%     1 
  Travel 2 50.0% 2 50.0% 4 
  Sleep 
disturbances 
3 75.0% 1 25.0% 4 
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Which time 
peak 
Early morning 
4 44.4% 5 55.6% 9 
2=2.42 P=0.48 
DF=3 NS 
  Afternoon 8 72.7% 3 27.3% 11 
  Evening 6 66.7% 3 33.3% 9 
  Night 1 100.0%     1 
Location of 
Head ache 
Once side 
16 69.6% 7 30.4% 23 
2=1.72 P=0.42 
DF=2 NS 
  Both side 1 50.0% 1 50.0% 2 
  Back of the 
head , along 
with neck 
2 40.0% 3 60.0% 5 
Pulsating 
quality 
Yes 
15 60.0% 10 40.0% 25 
2=0.71 P=0.39 
DF=1 NS 
  No 4 80.0% 1 20.0% 5 
Fatigue Yes 17 63.0% 10 37.0% 27 2=0.02 P=0.90 
DF=1 NS   No 2 66.7% 1 33.3% 3 
Photophobia Yes 13 54.2% 11 45.8% 24 2=2.59 P=0.10 
DF=1 NS   No 6 100.0%     6 
Phonophobia Yes 16 61.5% 10 38.5% 26 2=0.27 P=0.60 
DF=1 NS   No 3 75.0% 1 25.0% 4 
Vomiting Yes 12 75.0% 4 25.0% 16 2=2.01P=0.16 
DF=1 NS   No 7 50.0% 7 50.0% 14 
Sleep Sleep 
disturbance 
16 64.0% 9 36.0% 25 
2=0.03 P=0.88 
DF=1 NS 
  Normal sleep 3 60.0% 2 40.0% 5 
Investigations Yes 17 60.7% 11 39.3% 28 2=1.24 P=0.26 
DF=1 NS   No 2 100.0%     2 
 
 
The above table shows the association between Pretest level of pain in Control 
group with clinical  variables. None of the Patients are significantly associated with 
demographic variables.  It was confirmed using chi square test. 
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Table 15 
Association between posttest level of pain score and demographic variables 
(control) 
Demographic variables 
Posttest level of pain score 
n Chi square test No pain Mild Moderate 
f  % f  % f  % 
Age 21-30 years 
3 21.4% 9 64.3% 3 21.4% 14 
2=17.70P=0.05* 
DF=6 S 
  31-40 years 0 0.0% 5 62.5% 3 37.5% 9  
  41-50 years 0 0.0% 3 60.0% 2 40.0% 5  
  > 50  years 0 0.0% 2 100.0% 0 0.0% 2  
Gender Male 
0 0.0% 4 100.0% 0 0.0% 4 
2=2.67 P=0.26 
DF=2 NS 
  Female 3 11.5% 15 57.7% 8 30.8% 26  
Religion Hindu 
3 10.7% 19 67.9% 6 21.4% 28 
2=5.89 P=0.21 
DF=4 NS 
  Christian 0 0.0% 0 0.0% 1 100.0% 1  
  Muslim 0 0.0% 0 0.0% 1 100.0% 1  
Education Primary  
education 
0 0.0% 4 50.0% 4 50.0% 8 
2=11.42 P=0.18 
DF=8 NS 
  Secondary 
education 
2 28.6% 4 57.1% 1 14.3% 7 
 
  Higher 
secondary 
0 0.0% 5 62.5% 3 37.5% 8 
 
  Graduate 1 33.3% 2 66.7% 0 0.0% 3  
  No formal 
education 
0 0.0% 4 100.0% 0 0.0% 4 
 
Occupation Company 
0 0.0% 3 60.0% 2 40.0% 5 
2=4.32 P=0.82 
DF=8 NS 
  Daily wages 1 12.5% 6 75.0% 1 12.5% 8  
  Business 1 33.3% 1 33.3% 1 33.3% 3  
  Housewife 1 10.0% 6 60.0% 3 30.0% 10  
  Unemployed 0 0.0% 3 75.0% 1 25.0% 4  
Residence Rural 
3 17.6% 10 58.8% 4 23.5% 17 
2=2.56 P=0.28 
DF=2 NS 
  Urban 0 0.0% 9 69.2% 4 30.8% 13  
 
The above table shows the association between Posttest level of pain in Control 
group with Demographic Variables. Age 21-30 years 64.3%   had significant 
association of pain reduction than others, Chi square =17.70, p-value=0.03 
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Table 16 
Association between posttest level of pain score and Clinical variables (control) 
  
  
Posttest level of pain score 
n Chi square test No pain Mild Moderate 
f  % f  % f  % 
Dietary 
triggers 
Cheese 
2 16.7% 6 50.0% 4 33.3% 12 
2=5.78 
P=0.83 DF=10 
NS   Citrus fruits 0 0.0% 1 100.0% 0 0.0% 1 
  Coffee 0 0.0% 1 100.0% 0 0.0% 1 
  Missed meal 0 0.0% 4 100.0% 0 0.0% 4 
  Ice cream 1 16.7% 3 50.0% 2 33.3% 6 
  None 0 0.0% 4 66.7% 2 33.3% 6 
Frequency of 
head ache 
1 -2 times 
3 12.5% 17 70.8% 4 16.7% 24 
2=6.32 
P=0.04* 
DF=2 S   3 -4 times 0 0.0% 2 33.3% 4 66.7% 6 
How long the 
head ache 
will usually 
last(in hours) 
  
  
  
4 -10 1 5.9% 12 70.6% 4 23.5% 17 2=10.83 
P=0.11 DF=6 
NS 
11 -17 1  16.7%  2 33.3% 3 50.0% 6 
18 -24 1 33.3% 2 66.7% 0 0.0% 3 
> 24 
0 0.0% 3 75.0% 1 25.0% 4 
Any 
medication 
used 
Yes 
3 10% 19 63.3% 8 26.7% 30 
2=0.00 
P=1.00 DF=1 
NS 
  No 0 0% 0 0% 0 0% 0 
No of work 
days missed 
1 to 2days 
/3month 
0 0.0% 5 71.4% 2 28.6% 7 
2=5.26 
P=0.51 DF=6 
NS   3 to 4days 
/3month 
0 0.0% 1 100.0% 0 0.0% 1 
  >4days 
/3month 
1 50.0% 1 50.0% 0 0.0% 2 
  None 2 10.0% 12 60.0% 6 30.0% 20 
Other 
triggers 
Stressful 
event 
0 0.0% 7 53.8% 6 46.2% 13 
2=15.31 
P=0.36DF=14 
NS   Exposure to 
sunlight 
0 0.0% 2 100.0% 0 0.0% 2 
  Strong odor 0 0.0% 1 100.0% 0 0.0% 1 
  Loud noise 1 25.0% 2 50.0% 1 25.0% 4 
  Exposure to 
bright light 
0 0.0% 1 100.0% 0 0.0% 1 
  Fatigue 0 0.0% 1 100.0% 0 0.0% 1 
  Travel 2 50.0% 2 50.0% 0 0.0% 4 
  Sleep 
disturbances 
0 0.0% 3 75.0% 1 25.0% 4 
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Which time 
peak 
Early 
morning 
1 11.1% 6 66.7% 2 22.2% 9 
2=6.83 
P=0.33 
DF=6NS   Afternoon 0 0.0% 9 81.8% 2 18.2% 11 
  Evening 2 22.2% 4 44.4% 3 33.3% 9 
  Night 0 0.0% 0 0.0% 1 100.0% 1 
Location of 
H.A 
Once side 
2 8.7% 15 65.2% 6 26.1% 23 
2=1.31 
P=0.85 DF=4 
NS   Both side 0 0.0% 1 50.0% 1 50.0% 2 
  Back of the 
head , 
along with 
neck 
1 20.0% 3 60.0% 1 20.0% 5 
Pulsating 
quality 
Yes 
2 8.0% 16 64.0% 7 28.0% 25 
2=0.71 
P=0.70 DF=2 
NS   No 1 20.0% 3 60.0% 1 20.0% 5 
Fatigue Yes 3 11.1% 16 59.3% 8 29.6% 27 2=1.93 
P=0.38 DF=2 
NS 
  No 
0 0.0% 3 100.0% 0 0.0% 3 
Photophobia Yes 3 12.5% 14 58.3% 7 29.2% 24 2=1.50P=0.47 
DF=2 NS   No 0 0.0% 5 83.3% 1 16.7% 6 
Phonophobia Yes 3 11.5% 15 57.7% 8 30.8% 26 2=2.56 
P=0.28 DF=2 
NS 
  No 
0 0.0% 4 100.0% 0 0.0% 4 
Vomiting Yes 0 0.0% 13 81.3% 3 18.7% 16 2=5.99 
P=0.05* DF=2 
S 
  No 
3 21.4% 6 42.9% 5 35.7% 14 
Sleep Sleep 
disturbance 
0 0.0% 17 68.0% 8 32.0% 25 
2=17.12 
P=0.01** 
DF=2 S   Normal 
sleep 
3  60.0%  2 40.0% 0 0.0% 5 
Investigations Yes 3 10.7% 17 60.7% 8 28.6% 28 2=1.24 
P=0.54 DF=2 
NS 
  No 
0 0.0% 2 100.0% 0 0.0% 2 
 
 
The above table 16 shows the association between Posttest level of pain in 
Control group with clinical  variables.  Frequency of head ache patients 1-2 times  in a 
week had significant association Chi- square;6.32; p value=0.04 ,  patients had with 
vomiting significant  association Chi- square 5.99 ; p- value=0.05, and normal  sleep 
Patients had significant association Chi–square 17.12, p value = 0.01 with clinical 
variables. 
  
 
DISCUSSION 
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CHAPTER - V 
DISCUSSION 
 
This chapter deals with detailed discussion of the data and results interpreted 
from the statistical, inferential analysis report. The present study was focused to 
evaluate the effectiveness of cold pack application on acute episodic pain among 
patients with migraine in OPD at Government Rajaji Hospital, Madurai. Migraine is a 
recurrent type of headache in which is distressing and detrimental for the affected one 
causing serious impact in one’s personal life, productivity and job, it is a debilitating 
disorder characterized by moderate to severe headache which can be seen in all age 
groups at a rate varying from 40%. Migraineurs report either a significant reduction in 
their daily activity or a complete inability to function all together, missed work and 
lost productivity from migraine, create a significant public burden. During headache 
episodes people usually want to be left alone, being out of any direct light and remain 
in bed withdrawing from all activities. Migraine impacts patients and their families 
even between the attacks by limiting the patient participation in normal activities. 
People often need to modify their plans in fear of recurrent migraine attacks. Cold 
pack application has create numbing effect of vasoconstriction of peripheral nerves, to 
reduce the acute episodic pain among migraine patients.  
In this study, researcher adopted a Quantitative approach, True experimental 
pre-test post test only design and 60 samples were selected by Simple random 
sampling technique. Modified imogene kings theory was adopted. Pre test conducted 
to assess the symptoms Using international head ache society criteria, pain assessed 
by numerical rating scale Cold pack application given two times with half an hour 
interval and post test was conducted with the same tool using pain scale. 
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Discussion of socio demographic variables 
Regarding Age, majority of patients with migraine 11 (36.6%) had between 
the age 31-40 years in least 2(6.7%) had more than 50 years experimental group,             
14 (46.7%) had between the age 21-30 years, in least 2(6.7%) had more than 50 years 
in control group.  
  With regard to Gender, majority of patients with migraine 28 (93.3%.) had 
females and remaining 2 (6.7.%) had males in experimental group, 26(86.7%) were 
Females and remaining 4(13.3%) had males in Control group. 
  While comparing Religion majority of the patients with migraine 27(90.0%) 
belongs to Hindu, and 1 (3.3%) were Muslim in experimental group, 28(93.4%) were 
Hindu, 1(3.3%) were Christian, and Muslim in control group. 
  According to Education, majority 11(36.7%) had secondary education and 
remaining 3(10.0%) had No formal education in experimental group, 8(26.7%) had in 
primary education and minority 3(10.0%) had graduate educational status in control 
group. 
  By seeing Occupation, majority 13 (43.4%) were House wife, 3(10.0%) had 
unemployed in experimental group, 10(33.3%) were House wife, and least 3(10.0%) 
were Business in control group. 
  While discussing residence, majority18 (60.0%) hailed in Urban people, and 
least 12(40.0%) hailed in rural in experimental group and minority 17 (36.7%) hailed 
in rural, 13(43.3%) hailed in urban in control group. 
 
Discussion of clinical variables 
  Based on the Dietary Triggers, Majority 14 (46.7%) were taking cheese and 
least1(3.3%) had Citrus fruits and coffee in experimental group, 12(40.0%) had 
cheese, and least1(3.3%) had Citrus fruits and coffee in Control group.  
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  Regarding frequency of head ache majority of the patients 21(70.0%) had 1-2 
times attack in week and least 9(30.0%) had 3-4 times in experimental group, where 
as in control group 24(80.0%) had 1-2 times attack and remaining 6(20.0%) had 3-4 
times.  
  According to the How long Head ache will lost (in hours), majority of the 
patients 21 (70.0%) had pain 4-10 hours, and least 1(3.4%) had pain 11-17 hours in 
experimental group and in control group 17(56.7%) had pain 4-10 Hours, 3(10.0%) 
had18-24 Hours. 
  Discussing Medication used majority of the patients 30%(100%)had 
medication and least in experimental group, where as in control group 30(100%) had 
medication and least( 0%) with out medication both control and experimental group. 
  Based on Number of working days missed majority of the patients 21(70.0%) 
had none, of them missed and least 6(20.0%) had missed 1-2 days /3 month in 
experimental group, where as control group 20.0%) none of them missed and 
least1(3.3%) had 3-4 days/3month missed.  
  Discussing the other triggers, majority of the patients 15 (50%) had stressful 
event and least 1(3.3%) had triggered by exposure to bright light, fatigue and due to 
travel in experimental group, and in control group13(43.3%) had stressful event and 
least1(3.3%) had exposure to light, fatigue and odour. 
  Regard to which time pain in peak Majority of the patients 13(43.3%) had 
early morning, and least 3(10.0%) were had Evening and night in experimental group, 
and in control group11(36.7%) had afternoon ,and least1(3.3%)had pain in night.  
Based on Location of head ache, majority of the patients 20(66.7 %) had pain 
Once side and least 2(6.7%) had Both side in Experimental group, where as control 
group 23(76.7%) had Once side, least 2(6.7%) had both side. 
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  Assessed to Pulsating quality majority of the patients 28(93.3%) had pain 
pulsating quality least 2(6.7%) not a pulsating quality in Experimental group and then 
control group 25(83.3%) had pulsating quality, 5(16.7%) not a pulsating pain. 
  Discussing fatigue majority of the patients 27(90.0%) had fatigue, least 
3(10.0%) had not fatigue in Experimental group, in control group 27(90.0%) had 
fatigue, 3(10.0% ) not fatigue.  
Based on Photophobia majority of the patients 26 (86.7%) had photophobia, 
4(13.3%) none of them had photophobia experimental group, 24(80.0%) had 
photophobia, 6(20.0%) none of them had photophobia in control group. 
Regard to Phonophobia majority of the patients 25( 83.3%) had phonophobia, 
and least 5(16.7%) none of them had phonophobia in Experimental group, where as 
control group 26(86.7%) had phonophobia, least 4(13.3%) none of them had 
phonophobia. 
  Assessing on vomiting majority of the patients 18(60.0%) had vomiting, 
12(40.0%) had not vomited in Experimental group, 16(53.3%) had vomiting, least 
14(46.7%) remaining people not vomited in control group. 
Discussing sleep disturbances majority of the patients 22(73.3%) had 
disturbance and least 8(26.7%) had normal sleep in experimental group,25(83.3%) 
had disturbance least 5(16.7%) were normal sleep in control group.  
  Regard to under went radialogical Investigations majority of the patients 
23(76.7%) had investigated, least 7(23.3%) not done in Experimental group and in 
control 28(93.3%) had done, least2(6.7%) not done investigations.  
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Findings based on its objectives 
The first objective of the study was to assess the level of Acute Episodic pain 
among Patients with Migraine in OPD at Government Rajaji Hospital, Madurai. 
  In the pre test majority of the patients with migraine 16 (53.3%) had moderate 
level of Pain, 14 (46.7%) had severe (poor) level of pain in experimental group. where 
as in control group the pre test majority of the patient with migraine 19 (63.3%) had 
moderate level of pain, 11(36.7%) had severe level of pain. 
  The present study findings was supported by a study done by Kulkarni 
G,  RaoG et al (2010) to estimate the prevalence and disability burden attributed to 
migraine in Karnataka. Population based study involving in urban n=1,226 and rural 
n=1,103 populations subjects selected by random cluster sampling using a Modified 
Hardship questionnaire. Migraine was diagnosed as per ICHD-II criteria, Disability 
was assessed by HALT index. Age-standardized 1-year prevalence was 25.2% (95% 
CI: 23.9-27.4%; 10.6% definite, 14.6% probable migraine). And Point prevalence 
2.7%. was greater among females (31.6% vs 18.5%; or=2.03 [95% CI: 1.64-2.50]) 
and in rural areas (28.9% vs 21.7%; or=1.45 [95% CI: 1.16-1.82]). Prevalence peaked 
between 35-45 years in both genders. Median frequency was 24 days/year, with a 
sizeable minority (6.6%) reporting >60 days/year. Headache intensity was severe in 
40%. The overall mean total was 3.7 ±6.1 days/3 months, 6.1% of productive days, of 
which 2.1 ±4.0 days/3 months, people lost at home and 1.4 ±4.1 days/months and 
were lost in the work place. So the results revealed that Disability was higher among 
women and in rural areas.  
  The present study findings was supported by a study done by Teri Robert 
(2013) prevalence of head ache in India was 63.9%,with female preponderance 0f 4:3, 
migraine was25.2%, higher among females than males 2:1,among those rural area to 
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urban 1.5, tention type head ache 35.1%, all head ache ≥15 days/ month 3.0%, 
medication over use Head ache was 1.2%. 
The present study findings was supported by a cross sectional study Kathryn 
M Rexrode (2009) conducted in india among 2235 adults to determine the 
epidemiology and characteristics of primary recurrent head ache in indian adults. The 
finding revealed that age of first onset of headache was 11.33± 5.32 year with mean 
duration of head ache episode 4.23±3.77 hrs at a frequency of 4-8 headaches per 
month on an average. 
 
The second objective was to evaluate the effectiveness of cold pack application on 
acute episodic pain among patients with migraine in OPD at Government Rajaji 
Hospital Madurai. 
  In Experimental group the mean pretest pain score was 6.60with standard 
deviation of 0.77 and the mean post test pain score was 1.13 with standard deviation 
of 1.43 The mean difference is 5.47 .Percentage of mean score in the Pre test was 53.3 
% and in the Post test was 56.7%.The obtained student Paired “t” test value was 22.47 
which was significant at p <0.001 level. In control Group the mean pretest pain score 
was6.40 with standard deviation 1.13and mean posttest pain score3.17with standard 
deviation1.17. The mean difference3.23 percentage of mean score in pretest 
was63.3% and in the posttest was63.3%.Tobtained paired “ t” test value was 10.71 
which was significant at p< 0.001 level. This revealed that there was a significant 
difference in the mean Pain scores between the pretest and posttest. Comparison of 
pretest and posttest cold pack application result also revealed a significant reduction 
in pain score by chi square test p at 0.001*** level of significant. The difference was 
due to the intervention, cold pack application. Hence this study proved that the cold 
pack application was very effective in reducing pain among patients with migraine. 
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  The study findings was supported by Friedman et al.(2011) conducted a 
study to efficacy of a non-invasive technique, intra-oral chilling, for acute migraine 
headache pain when compare with oral sumatriptan or placebo. Fifty participants 
involved in study, 9% of migraine patients reported that a cold therapy was almost 
completely effective, 26.5% moderately effective and 29.0% mildly effective. 
However, As a result, revealed that of cold therapy is used for migraine patients as an 
alternative or additive modality to reduce the pain level.  
 
Thus the Hypothesis H1: There is a significant difference between pretest and 
posttest level of acute episodic pain among intervention group patients with 
migraine, in OPD at Government Rajaji Hospital, Madurai was accepted.  
The study supported by a study done dy John F. Rothrock, M.D., Conducted 
a study at University of California, San Diego (UCSD) Medical Center. A clinical 
study of I.C.E. DOWN was performed on 25 patients with migraine and 25 patients 
with muscle tension headaches, or both, were Involved in the study. Only patients 
with a minimum of 10 headaches within 2 months study subjects used to evaluated 
recent headache history, headache frequency, duration and intensity, among migraine 
patients were taking some form of medication for their headache and each agreed to 
stop their drug treatment for the duration of the study. Each subjects was supplied 
with the I.C.E.DOWN cold therapy head wrap and asked to use it in the event of a 
recurrence of a typical headache and was followed for a two-month period and at the 
end of that time an evaluation was done on each patient. The results 73% of the 
patients improved beginning the use of I.C.E. DOWN, 83% would prefer using I.C.E. 
DOWN instead of a drug. 80% would recommend I.C.E. DOWN to their friends or 
family, 76% stated I.C.E. DOWN reduced pain .and throbbing and 66% stated I.C.E. 
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DOWN lessened the severity of pain, 53% stated I.C.E. DOWN helped to relieve 
muscle tension. 
 
Thus the Hypothesis H2: There is a significant difference between the posttest 
level of acute episodic pain among intervention group, and control group 
patients with migraine in OPD at Government Rajaji Hospital, Madurai was 
accepted.  
 
The third objective of the study was to associate the level of acute episodic pain 
among patients with migraine with their selected socio demographic variables 
and clinical variables, in OPD at Government Rajaji Hospital, Madurai.  
 
Chi square analysis was done to find out the association between the post test 
scores of acute episodic pain and selected socio demographic variables and clinical 
variables. The study revealed a significant association between the level of acute 
episodic pain and selected socio demographic variables such as age those who had > 
21-30 years( x2 = 9.91 P-0.02)and those who have frequency of head ache 1-2 times 
in a week (x2=6.21 p-0.01), those who had vomiting(x2= 5.79p-0.02 ), those who had 
Sleep disturbances (x2=4.22p-0.04 the clinical variables such as significant 
association with pain , among patients with migraine .  
  
  It was also supported by the study done by Adam S Sprouse-Blum, 
MD,(2013) study utilizing an adjustable neoprene neck wrap that holds two freezable 
ice packs and The study was approved by the institutional review boards Frozen or 
non-frozen (control)participants involved in the study and also Participants were 
educated about cold therapy is the most common self-care treatment in migraine, and 
that this study evaluates this method of treatment in a novel location at the neck Wrap 
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101 participants were met IHS ICHD-2 criteria for migraine and were , 25.5% (n=14) 
met IHS criteria for migraine with aura, the rest (74.5%) met criteria for migraine 
without aura the results showed that 85.5% of participants (n=47) were female, 
Participant ages varied from 19 to 64 with a mean age of 43.1 ± 11.4 years, and the 
results showed that frequency of migraine attacks less than one per month with a 
median frequency of 5.5, an interquartile range of 4.63 (25th percentile) and 28.75 
(75th percentile).So frozen neck wrap was significantly more effective for decreasing 
pain score, decrease in vascular permeability and a decrease in local nociceptive 
stimulation. 
 
Thus the Hypothesis H3-There is a significant association between the level of 
acute episodic pain among patients with migraine and their selected socio 
demographic variables and clinical variables in OPD at Government Rajaji 
Hospital, Madurai was accepted. 
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CHAPTER – VI 
SUMMARY, CONCLUSION, IMPLICATIONS AND 
RECOMMENDATIONS 
 
  This chapter narrates the summary of the study and the conclusion drawn. It 
also describes the implications for different areas like nursing education, nursing 
administration, nursing practice and nursing research. It provides the 
recommendations based on the study. 
 
6.1 Summary 
The present study was conducted to evaluate the effectiveness of Cold pack 
application on Acute episodic pain among patients with migraine in OPD at 
Government Rajaji Hospital, Madurai. 
 
Objectives 
1. To assess the level of acute episodic pain among patients with migraine both 
intervention group, and control group in OPD at Government Rajaji Hospital, 
Madurai.  
2. To evaluate the effectiveness of cold pack application on acute episodic pain 
among patients with migraine Intervention group in OPD at Government 
Rajaji Hospital Madurai. 
3. To associate the level of acute episodic pain among patients with migraine in 
OPD at Government Rajaji Hospital, Madurai with their selected socio 
demographic variables. 
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The following hypotheses were tested at 0.001 level 
H1 - There is a significant difference between pretest and post test level of acute 
episodic pain among intervention group patients with migraine in OPD at 
Government Rajaji Hospital, at Madurai.  
H2 There is a significant difference between pretest and post test   level of acute 
episodic pain among intervention group and control group patients with migraine in 
OPD at Government Rajaji Hospital, at Madurai 
H3 - There is a significant association between the level of acute episodic pain among 
patients with migraine with their selected demographic variables. 
 
Assumptions:  
Patients with migraine may have experience varying level of pain. 
The study was conducted at OPD of Neuro medicine at Government Rajaji 
Hospital, Madurai. The conceptual framework adopted was Modified Imogene king 
goal attainement theory. Quantitative approach – True -experimental, pre test post test 
only design was adopted. The independent variable was cold pack application and the 
dependent variable was acute episodic Pain. Probability Simple random sampling 
technique was adopted to select 60 samples by picking up the available samples who 
fulfill the inclusion criteria during the period of data collection. The accessible 
population for the study was patients with migrainein OPD of Neuro medicine at 
Government Rajaji Hospital, Madurai. Intervention carried out is Cold pack 
application. 
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The tool used in this study consists of two sections. 
Section I 
a. Socio demographic variables 
b. Clinical Variables 
 
Section II 
International Head ache Society criteria- II 
Content validity was obtained from five experts in the field of Medicine and 
Medical surgical nursing. Pilot study was conducted to find out the feasibility of the 
study and it did not show any major flaw in the design of the study. On the 1st day, 
After data collection with, Interternational head ache society criteria- 2 the level of 
acute episodic pain was assessed and followed by Cold pack application two times a 
day with half an hour Interval morning and post test was taken. Data was collected for 
six weeks from 20.3.17 to 30.4.17 and based on the objectives and hypothesis, data 
were analyzed using descriptive and inferential statistics. 
 
6.2 Major findings of the study 
  Regarding Age, majority of patients with migraine 11(36.6%), between                
31-40 years, in Experimental group, In Control group 14(46.7%%) between 21-30 
years.  
With regard to Gender, majority of patients with migraine 28(93.3%) were 
Females in experimental group, and in Control group 26(86.7%) were females. 
  While comparing Religion majority of the patients with migraine 27(90.0%) 
belongs Hindu in experimental group and in Control group 28(93.4%) belongs to 
hindu. 
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While comparing Education, majority of the patients with migraine 
11(36.7%) in experimental group had Secondary education, and in control group                  
8(26.7%) had primary education. 
  According to Occupation, majority of patients with migraine 13(43.4%) were 
in House wife in experimental group, in Control group 10(33%.) were House wife. 
By seeing Residence majority of patients with migraine 18 (60.0%) were 
Urban in experimental group, in Control group.17 (56.7%) were rural. 
  Assessing Dietary triggers, Majority of patients with migraine In 
experimental group 14(46.7%) were taking Cheese, 6(20.0%) had None of dietary 
trigger, 5(16.7%) had Ice Cream, 3(10.0%) had missed meal, and remaining 1(3.3%) 
had Citrus fruits, and coffee. In Control group 12(40.0%) had Cheese, 6(20.0%) had 
Ice Cream, and none of dietary trigger, 4(13.4%) were missed meal, 1(3.3%) had 
Citrus fruits and coffee. 
Observing Frequency of Head ache, majority of the Patients with Migraine 
In Experimental group 21(70.0%) had 1- 2 times attack per week, 24(80.0%) were 1-2 
times per week in control group. In minor 24(30.0%) had 3- 4 times attack per week, 
6(20.0%) were 3-4 times per week in control group. 
  According to the How long Head Ache will Lost(in hours), majority of the 
Patients with migraine In experimental group 21(70.0%) had pain 4-10 Hours, 
4(13.3%) had pain 18-24 Hours, and >24 Hours and remaining 1(3.4%) had 11-17 
Hours. In Control group 17(56.7%) had pain 4-10 Hours, 6(20.0%) had 11-17 Hours, 
and remaining 4(13.3%) had >24 Hours, 3(10.0%) had 18-24 Hours. 
  While assessing on Number of working days Missed, majority of the 
Patients with migraine In experimental group 21(70.0%) None of them absent, 
6(20.0%) had 1-2 days missed/3 month, 2(6.7%) had 3-4 days missed/3 month, 
85 
 
1(3.3%) had >4 days missed/3 month. In Control group 20(66.7%) had None of them 
absent, 7(23.3%) had1-2 days missed/3 month, 2(6.7%) had >4 days missed/3 month 
and remaining 1(3.3%) had 3-4 days missed/3 month. 
  Discussing the other triggers, majority of the Patients with Migraine In 
experimental group 15(50.0%) had Stressful event, 4(13.3%) had Exposure to 
sunlight, 3(10.0%) had Strong Odour, and Sleep disturbances, 2(6.7%) had Loud 
noice, 1(3.3%) had exposure to Bright light, Fatigue, and Travel. In Control group 
13(43.3.%) had Stressful event , 4(13.3.%) had Loud noise ,Sleep disturbances, and 
Travel, 2(6.7%) had Exposure to sun light,1(3.3%) had exposure to Bright light, 
Strong Odour and Fatigue. 
  Based on Which time pain in Peak majority of the Patients with Migraine In 
experimental group 13(43.3%) had pain in early morning, 11(36.7%) had pain in after 
noon, 3(10.0%) had pain in evening, and night. In control group 11(36.7%) had pain 
in afternoon, 9(30.0%) had pain in early morning, and evening, 1(3.3%) had pain in 
Night. 
Discussing the Location of Head ache majority of the Patients with Migraine 
In experimental group 20(66.7%) had pain One side, 8(26.6%) had pain back of the 
head along with neck, 2(6.7%) had both side. In Control group 23(76.7%) had pain in 
One side, 5(16.6%) had pain in Back of the head along with neck, 2(6.7%) had pain in 
both side Assesssing to Pulsating quality pain majority of the Patients with migraine 
In experimental group 28(93.3%) had pulsating pain Remaining 2(6.7%) none of 
them had pulsating pain. In Control group 25(83.3%) had pulsating pain, remaining 
5(16.7%) none of them had pulsating pain. 
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Based on Fatigue majority of the Patients with migraine In experimental 
group 27(90.0%) had fatigue 3(10.0%) none of them had fatigue both experimental 
and control group. In control group 27(90.0%) had fatigue.  
  Assessing on Photophobia majority of the Patients with migraine In 
experimental group 26(86.7%) had photophobia, 4(13.3%) none of them had 
photophobia. In control group 24(80.0%) had photophobia, 6 (20.0%) none of them 
had photophobia.  
  Collecting data on Phono phobia majority of the Patients with migraine In 
experimental group 25(83.3%) had phonophobia, 5(16.7%) none of them had 
phonophobia. In control group 26(86.7%) had phonophobia 4(13. 3%) none of them 
had phonophobia 
  While assessing the vomiting majority of the Patients with Migraine In 
Experimental group 18(60.0%) had vomiting, 12(40.0%) none of them had vomiting. 
In control group 16((53.3%) had vomiting,14(46.7%) none of them had vomiting. 
  Discussing to Sleep disturbance majority of the Patients with migraine In 
experimental group 22(73.3%) had sleep disturbance, 8(26.7%)had normal sleep. In 
control group 25((83.3%) had sleep disturbance, 5(16.7%) had normal Sleep. 
  Based on radiological investigations majority of the Patients with Migraine 
In Experimental group 23(76.7%) were investigated, 7(23.3%) none of them had 
investigated. In control group 28((93.3%) were investigated, 2(6.7%.) none of them 
had investigated. 
In experimental group the majority of patients with migraine pretest level of 
pain (53.3%) were moderate pain, (46.7%)were Severe pain, in posttest (56.7%) had 
no pain, 43.3% were mild pain, No one had severe level of pain, moderate level of 
pain. In Control group during pretest level of pain (63.3%) had moderate pain, 
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(36.7%) had Severe pain, in posttest (10.0%) had no pain, 63.3% were mild pain, 
26.7% had moderate level of pain, No one had severe level of pain. 
  The pre test Mean pain score in experimental group was 6.60 with the 
Standard Deviation 0.77, but in the post test Mean pain score was 1.13 with the 
Standard Deviation 1.43. In Control group pretest and posttest level of pain score 
Mean 6.40and 3.17, so the Mean difference is 3.23, The difference between pretest 
and posttest score is large and it is statistically significant. 
In experimental group had 54.7% pain reduction, where as in control group 
had 32.3% pain reduction after with out intervention. Differences between pretest and 
posttest score was analyzed using mean difference with 95% confidence interval The 
student paired ‘t’ test value was 22.47 which was very high significant at P< 0.001 
level. The effectiveness of cold pack application on acute episodic pain, Control 
group, obtained t- value in posttest is 10.71 at p value ≤0.001*** Level of significance. 
This 22.4% Reduction difference score shows the effectiveness of study. 
  A significant association of post test level of pain in experimental group 
88.9% between 21-30 years, had pain reduction than others. Chi square value=9.91,       
p-value=0.02 statistically significant. Frequency of head ache 1-2 times in a week 
71.4% in experimental group chi square value=6.21, p-value=0.01,those who had 
vomiting 83.3% chi square value 5.79,p-value=0.02 in, Normal sleep pattern patients 
87.5% had pain reduction chi square value=4.22, p-value =0.04. this variables highly 
significant association. 
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6.3. Conclusion 
The statistical evidence proved that the cold pack application provided by the 
researcher was very effective in reducing acute episodic pain level among the patients 
with Migraine. Hence the researcher concluded that the Cold pack application can be 
provided among patients with Migraine experimental group had significant reduction 
of pain than control group.  
 
6.4 Implications 
The investigator had drawn several implications from this study for various 
areas such as nursing practice, nursing education, nursing administration and nursing 
research. 
 
6.4.1 Implications for nursing practice 
 Nurses should take responsible for the Pain assessment of the patients with 
migraine to provide cold pack application intervention can be followed as it is 
effective in reducing pain level, in out patient department of Neuro medicine.  
 patients with migraine pain assessment should be considered as a part of the 
nurses important assessment to identify health condition of the patient 
 One of the non pharmacological intervention to reduce the pain level with in 
short period more over it reduces cost of treatment and side effect of 
treatments like drug induced headache.  
 
6.4.2 Implications for nursing education 
  Nurse educator educate needs to understand health problem that is essential to 
reduce the level of pain among migraine patients. 
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Nursing curriculum to be strengthened for improving nursing practice in 
various setting  Effective care is important for the patients with migraine It prevents 
the further attack of migraine. 
  The frequency of cold pack intervention will provide better results of the 
patient’s condition. 
The study will enable the students to practice of cold pack intervention for 
migraine for reduce the pain level.  
 
6.4.3 Implications for Nursing Administration 
 Nursing administration play a vital role in supervision and management of 
nursing services Administrator should pay special attention to new as well as 
migraine patient to educate and evaluate their cold pack application in the 
benefited units. 
 Administrator can encourage the nurses to assess the level of pain by using 
pain rating score  
 All the patients and make it as one of the pain assessment procedure. 
 Articles and materials needed for providing cold pack intervention must be 
made available by the Administrative department. 
 Nursing Administrator can formulate protocols to incorporate the other non 
pharmacological managements  
 In service education programme can be conducted to disseminate the research 
 
6.4.4 Implications for nursing research 
 This study can be a baseline for future studies to build upon and motivate  
 A study can be done with large samples and also for long duration. 
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 A study can be done with other intervention measurers and effectiveness can 
be analyzed in the acute episodic pain. 
 Research is also needed to determine the impact of migraine on patient’s 
outcome. 
 
6.5 Recommendations: 
 A similar study can be replicated with larger sample for better generalization 
 A study can be conducted using other relaxation techniques like yoga, 
biofeedback ,neck massage ,muscle relaxation 
 A study can be conducted to assess the knowledge, attitude and practice of 
 nursing staff regarding pain management. 
 The effectiveness of coldpack intervention can be tested for other disease 
conditions, injury.  
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APPENDIX-V 
SECTION-A 
TOOLS FOR DATA COLLECTION: 
DEMOGRAPHIC DATA: 
1. Age 
a) 21-30 years 
b) 31-40 years 
c) 41-50 years 
d) > 50  years 
2. Gender 
             a)Male 
             b)Female 
3. Religion  
                  a)Hindu 
                  b) Christian 
                  c)Muslim  
                  d) Others 
4. Education  
a) Primary  education 
b) Secondary education 
c) Higher secondary 
d) Graduate 
e) No formal education 
5. Occupation  
a) Company 
b) Daily wages 
c) Business 
d) Housewife 
e) Unemployee 
6. Residence 
a) Rural 
b) Sub-urban 
c) Urban 
d) Tribal area 
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SECTION  B 
Clinical variable 
1) Dietary triggers of migraine as per your experience 
A. Cheese 
B. Chocolates 
C. citrus fruits 
D. junk food 
E. Coffee 
F. Missed meal  
G. Ice cream 
H. Pickle  
I. None 
2) Frequency of head ache (intimes/week) 
a) 1to2 
b) 3to4 
c) >5 
3) How long the head ache will usually last (in hours) 
a) 4to10 
b) 11to17 
c) 18to24 
d) >24 
4) Prescribed medications   
a)  yes 
b)    No 
5) Number of working days missed due to headache 
a) 1to2days /3month 
b) 3to4days /3month 
c) >4days /3month 
d) None 
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6) Other head ache triggers 
a) Stressful event  
b) Exposure to sunlight  
c) Strong odor 
d) Loud noise 
e) Exposure to bright light  
f) Fatigue  
g) Travel  
h) Sleep disturbances 
i) Smoking 
j) Alcoholism 
k) None 
 
7) Which part of the day migraine is at its peak 
a) Early morning  
b) Afternoon  
c) Evening  
d) Night 
 
8) Location of migraine head ache                                                           
       a) Once side                                                                                                                                                                                                       
       b) Both side 
      c) Forehead 
      d) Back of the head , along with neck 
 
9) Pulsating quality 
      a) yes 
      b) No 
 
10) Do you have fatigue  due to head ache? 
    a) yes 
    b) No 
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11) Photophobia 
a) yes  
b) No 
 
12) phonophobia  
a) yes  
b) No 
 
13) Nausea/ vomiting 
     a) yes  
     b)No 
 
14)Sleep  quality 
  a) Sleep disturbance 
    c) Normal sleep 
 
15) Have you underwent  any  Investigation ? 
  a)  Yes  
  b) No 
 
 
 
 
 
 
 
 
 
108 
 
 
SECTION - II 
 
 
 
 
 
 
 
 
 
109 
 
INTERNATIONAL HEAD ACHE SOCIETY  DIAGNOSTIC CRITERIA  
 Migraine without aura 
 A. At least five attacks fulfilling criteria B–D 
 B. Headache attacks lasting 4-72 hours (untreated or unsuccessfully treated) 2,3 
 C. Headache has at least two of the following four characteristics:  
1. Unilateral location  
2. Pulsating quality 
3. Moderate or severe pain intensity 
 4. Aggravation by or causing avoidance of routine physical activity (e.g. walking or 
climbing stairs) 
 D. During headache at least one of the following:  
     1. Nausea and/or vomiting 
     2. Photophobia and phonophobia  
 Migraine with  aura 
A. At least two attacks fulfilling criteria B and C 
B.  One or more of the following fully reversible aura symptoms: 
     1. Visual 
     2. Sensory  
     3. Speech and/or language 
     4. Motor 
     5. Brainstem 
     6. Retinal 
 C. At least two of the following four characteristics: 
1.  At least one aura symptom spreads gradually over 5 minutes, and/or two or more 
symptoms occur in succession  
2.  Each individual aura symptom lasts 5-60 minutes 
3.  At least one aura symptom is unilateral 
4.  The aura is accompanied, or followed within 60 minutes, by headache 
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APPENDIX - IX 
COLD PACK APPLICATION PROCEDURE 
Cold pack application is a procedure to apply an ice or cold gel pack to a specific 
body part to relieve pain, muscle strain, swelling, and inflammation.  
 
PURPOSES  
 To relieve pain of muscle stria 
 To relieve congestion/oedema 
 To relieve urinary tract infection 
 To reduce infiamation 
 To reduce the temperature 
 
CONTRAINDICATIONS  
 Hypothermia 
 Musle spasm 
 Peripheral neuropathy 
 Cold intolerance 
 
ARTICLES NEEDED FOR THE COLD PACK APPLICATION 
 Cold pack  
 Small towel-2 
 Ice pack-4 
 Vaccine carrier or thermocool container 
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COLD PACK CONTAINS 
Mix 3 cups (710 mL) water and 1 cup (235 mL) rubbing alcohol in a freezer bag. 
Seal the bag and place it in the freezer until slush forms. Refreeze the bag when the slush 
melts. cold packs that can be reusable Store them in refrigerator to freeze.  
Cold pack contains water mix with ammonium nitrate,or calcium ammomium 
nitrate and urea. 
 
Procedure for col pack application 
S.NO NURSING ACTION RATIONALE 
1. Asses the level of pain on migraine 
patients scored by numerical rating scle 
To know the level of pain 
2. Identify the patients, check physician 
order 
To ensure right procedure to the 
right person 
3 Provide explanation and get consent 
from the subjects 
Promotes patients cooperation and 
participation 
4 Cold pack keep it in refrigerator thirty 
minutes for freeze 
Slush formation, effect of the 
intervention 
5 After that wraped in small towel to apply 
fore head for 20 minutes intermittently 
Application beyond this time causes 
secondary effects 
6 During  application check tolerance 
cyanosis and mottling 
Identifies complications an early 
stage 
7 After completion of the intervention 
pack cover is removed and re freeze the 
cold pack 
Effect of the procedure is monitored 
8 Half an hour interval second application 
provided pain measured by numerical 
rating scale. 
Ensure maximum benefit of the 
intervention,to reduce the frequency 
of attack  
9  Finally replace the articles and record 
the procedure 
To have proper documentation. 
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